Advertisement

Hereditäre Myopathien

Conference paper
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 28)

Zusammenfassung

Es sollen hier die Störungen abgehandelt werden, die infolge genetischer Fehlinformation ausschließlich oder unabhängig vom gleichzeitigen Befall anderer Organsysteme primär die Muskelzelle betreffen.

Abkürzungen

GOT

Glutamat-Oxalacetat-Transaminase

GPT

Glutamat-Pyruvat-Transaminase

CPK

Kreatinphosphokinase

LDH

Laktatdehydrogenase

MDH

Malatdehydrogenase

RNS

Ribonucleinsäure

DNS

Desoxyribonucleinsäure

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Muskeldystrophie

  1. Aebi, U., u. R. Richterich: Aktuelles zur Biologie der Enzyme. Helv. med. Acta 30, 353 (1963).PubMedGoogle Scholar
  2. Aebi, U., R. Richterich, J. P. Colombo, and E. Rossi: Progressive muscular dystrophy. II. Biochemical identification of the carrier state in the recessive sex-linked juvenile (Duchenne) type by serum creatine-phosphokinase determinations. Enzymol. biol. clin. J. 1, 61 (1961/62).Google Scholar
  3. Aebi, U., R. Richterich, H. Stillhart, J. P. Colombo u. E. Rossi: Progressive Muskeldystrophie. III. Serumenzyme bei der Muskeldystrophie im Kindesalter. Helv. Paediat. Acta 16, 543 (1961).PubMedGoogle Scholar
  4. Allen, J. D., and D. W. Rodgin: Mental retardation in association with progressive muscular dystrophy. Amer. J. Dis. Child. 100, 208 (1960).PubMedGoogle Scholar
  5. Ames, S. R., and H. A. Risley: Aminoaciduria in progressive muscular dystrophy. Proc. Soc. exp. Biol. (N. Y.) 68, 131 (1948).Google Scholar
  6. Amick, L. D., W. W. Johnson, and H. L. Smith: Electromyographic correlations in arthrogryposis. Arch. Neurol. 16, 512 (1967).PubMedCrossRefGoogle Scholar
  7. Amyot, R.: Hereditary, familial and acquired ptosis of late onset. Canad. med. Ass. J. 59, 434 (1948).Google Scholar
  8. Amyot, R., Ptosis hereditaire familial et tardif des paupières supérieures. Pharyngeplégie également héréditaires et familiale, concomitante. Un. méd. Can. 77, 1288 (1948).Google Scholar
  9. Aran, F. A.: Recherches sur une maladie non encore decrite du systeme musculaire (atrophie musculaire progressive). Arch. gén. Méd. 24, 5 (1850).Google Scholar
  10. Aronson, S. B., and B. W. Volk: Tissue and serum aldolase in neuromuscular disease. Arch. Neurol. Psychiat. (Chic.) 75, 568 (1956).Google Scholar
  11. Aronson, S. M., and B. W. Volk: Studies on serum aldolase activity in neuromuscular disorders. I. Clinical applications. Amer. J. Med. 22, 414 (1957).Google Scholar
  12. Barbeau, A.: Ocular myopathy in French Canada. In: Neuromuskuläre Erkrankungen. 8. Internationaler Kongreß für Neurologie, Berichte, TOM II, Wien 1965.Google Scholar
  13. Barnes, S.: A myopathic family with hypertrophic, pseudohypertrophic, atrophic and terminal (distal in upper extremities) stages. Brain 55, 1 (1932).CrossRefGoogle Scholar
  14. Barwick, D. D.: Investigations of the carrier state in the Duchenne type dystrophy. In: Research in muscular dystrophy. Proceedings 2nd Symposium on Current Research in Muscular Dystrophy. London: Pitman 1963.Google Scholar
  15. Barwick, D. D., D. J. Newell, and J. N. Walton: Methandrostelone and nandrolone decanoate in muscular dystrophy. A controlled trial. Neurology 13, 12 (1963).PubMedGoogle Scholar
  16. Baston, J. A.: Treatment of muscular dystrophy. Mod. Treatment (N. Y.) 3, 298 (1966).Google Scholar
  17. Becker, P. E.: Die Einteilung der Muskeldystrophien (Ein Beitrag zur Systematik der Heredodegenerationen). Nervenarzt 13, 209 (1940).Google Scholar
  18. Becker, P. E., Die Myopathien. Fortschr. Neurol. Psychiat. 14, 283 (1942).Google Scholar
  19. Becker, P. E., Eine klinisch-genetische Untersuchung der Dystrophia musculorum progressiva (Erb.) Arch. Psychiat. Nervenkr. 189, 1 (1952).CrossRefGoogle Scholar
  20. Becker, P. E., Dystrophia musculorum progressiva. Stuttgart: Thieme 1953.Google Scholar
  21. Becker, P. E., Zur Genetik der Muskeldystrophien. Arch. Klaus-Stift. Vererb.-Forsch. 33, 32 (1958).Google Scholar
  22. Becker, P. E., Two new families of benign sex-linked recessiv muscular dystrophy. Rev. canad. Biol. 21, 551 (1962).PubMedGoogle Scholar
  23. Becker, P. E., Myopathien. In: Handbuch der Humangenetik, Bd. 3, S. 1. Hrsg. P. E. Becker. Stuttgart: Thieme 1964.Google Scholar
  24. Becker, P. E., Zur Genetik der Muskeldystrophien. 8. Intern. Kongr. f. Neurol., Berichte TOM II. Vienna (1965).Google Scholar
  25. Becker, P. E., Neues zur Genetik der Myopathien. Wien. klin. Wschr. 79, 402 (1967).PubMedGoogle Scholar
  26. Becker, P. E., u. F. Kiener: Eine neue x-ehromosomale Muskeldystrophie. Arch. Psvchiat. Nervenkr. 193, 427 (1955).Google Scholar
  27. Beckett, E. B., and G. H. Bourne: The histochemistry of normal and abnormal human muscle. Proc. roy. Soc. Med. 50, 308 (1957).Google Scholar
  28. Beckmann, R.: Zum Verhalten der Serumaldolaseaktivität bei Patienten mit Dystrophia musculorum progressiva Erb. Klin. Wschr. 33, 179 (1955).PubMedCrossRefGoogle Scholar
  29. Beckmann, R., Über den heutigen Stand der Therapieversuche bei der Dystrophia musculorum progressiva Erb. Arch. Kinderheilk. 159, 217 (1959).Google Scholar
  30. Beckmann, R., Pathogenetische Grundlagen und Erfahrungen bei Behandlungsversuchen der Dystrophia musculorum progressiva Erb. Ärztl. Forsch. 17, 20 (1963).Google Scholar
  31. Beckmann, R., u. E. Mölbert: Biochemische und elektronenmikroskopische Befunde bei progressiver Muskeldystrophie. Mschr. Kinderheilk. 110, 216 (1962).PubMedGoogle Scholar
  32. Beckmann, R., u. H. Nawrath: Sozialmedizinische Situationen bei Patienten mit progressiver Muskel-dystrophie in der Bundesrepublik und anderen Ländern unter Berücksichtigung der Hilfsmöglichkeiten nach dem Bundessozialhilfegesetz. Med. Welt 18, 1993 (1964).Google Scholar
  33. Beckmann, R., u. V. von Osten: Therapeutische Möglichkeiten bei progressiver Muskeldystrophie. Dtsch. med. Wschr. 91, 108 (1966).PubMedCrossRefGoogle Scholar
  34. Beckmann, R., u. H. Ritter: Aminosäuren-Fleckenkartenbefunde bei progressiver Muskeldystrophie. Dtsch. med. Wschr. 91, 2331 (1966).CrossRefGoogle Scholar
  35. Bekeny, G., F. Kraft U. S. Lang: Die Anwendung von Durabolin (19/Nor-Androstenophenylproprionat) in der Behandlung der Dystrophia musculorum progressiva. Nervenarzt 31, 118 (1960).PubMedGoogle Scholar
  36. Bell, C. D., and P. E. Conen: Change in fiber size in Duchenne muscular dystrophy. Neurology 17, 902 (1967).PubMedGoogle Scholar
  37. Benedict, J. D., H. J. Kalinsky, L. A. Scarrone, A. R. Wertheim, and D. W. Stetten, Jr.: The origin of urinary creatine in progressive muscular dystrophy. J. clin. Invest. 34, 141 (1955).PubMedCrossRefGoogle Scholar
  38. Bergamini, V., et P. Baggiore: La nivalinoterapia in alcune malattie neurologiche. Minverva Med. 51, 3553 (1960).Google Scholar
  39. Berger, H.: Aminoaciduria in progressive muscular dystrophy. Rev. canad. Biol. 21, 567 (1962).PubMedGoogle Scholar
  40. Biemond, A.: Myopathia distalis juvenilis hereditaria. Acta psychiat. scand. 30, 25 (1955).Google Scholar
  41. Blahd, W. H., F. K. Baxter, R. L. Libby, and A. S. Rose: Studies in neuromuscular diseases with radioactive potassium. Neurology 3, 604 (1953).PubMedGoogle Scholar
  42. Blahd, W. H., F. K. Baxter, R. L. Libby, and A. S. Rose, Radioisotope studies in neuromuscular disease. 2. Studies in muscular dystrophy and myotonia dystrophica with sodium 22 and potassium 42. Neurology 5, 201 (1955).PubMedGoogle Scholar
  43. Blahd, W. H., A. Bloom, and W. Drell: Qualitative study of aminoaciduria in muscular dystrophy and myotonia dystrophia. Proc. Soc. exp. Biol. (N. Y.) 90, 704 (1955).Google Scholar
  44. Blahd, W. H., B. Cassen, and M. Lederer: Body potassium content in patients with muscular dystrophy. Ann. N. Y. Acad. Sci. 110, 282 (1963).PubMedCrossRefGoogle Scholar
  45. Blahd, W. H., B. Cassen, and M. Lederer, Decreased body potassium in nondystrophic relatives of patients with muscular dystrophy. A biochemical trait. Med. Intelligence 270, 197 (1964).Google Scholar
  46. Blahd, W. H., B. Cassen, and M. Lederer, The significance of decreased body potassium concentrations in patients with muscular dystrophy and nondystrophic relatives. New Engl. J. Med. 276, 1349 (1967).Google Scholar
  47. Blietz, R. J.: Treatment of progressive muscular dystrophy by combined infusions of glucose and insulin. German med. Mth. 11, 280 (1966).Google Scholar
  48. Blietz, R. J., u. F. Paulmann: Glucose-Assimilation und Insulinwirkung bei x-chromosomaler recessiv erblicher Muskeldvstrophie (Typ Duchenne) im Belastungstest. Hoppe-Seylers Z. physiol. Chem. 347, 35 (1966).PubMedCrossRefGoogle Scholar
  49. Blyth, H., and R. J. Pugh: Muscular dystrophy in childhood. The genetic aspect. A field study in the Leeds region of clinical types and their inheritance. Ann. hum. Genet. 23, 127 (1958/59).Google Scholar
  50. Boellner, S. W., E. J. Olson, D. Fredrickson, and E. R. Hughes: Plasma and erythrocyte magnesium in muscular dystrophy. Amer. J. Dis. Child. 110, 172 (1965).PubMedGoogle Scholar
  51. Boman, K., and E. Hokkanen: Progressive muscular dystrophy in monozygotic twins. Acta neurol. scand. 42, 97 (1966).CrossRefGoogle Scholar
  52. Van den Bosch, J.: Investigations of the carrier state in the Duchenne type dystrophy. In: Research in muscular dystrophy. Proceedings 2nd Symposium on Current Research in Muscular Dystrophy. London: Pitman 1963.Google Scholar
  53. Boyer, S. H., and D. C. Fainer: Genetics and diseases of muscle. Amer. J. Med. 35, 622 (1963).PubMedCrossRefGoogle Scholar
  54. Bramwell, E.: Observations on myopathy. Section of neurology. Proc. roy. Soc. Med. 16, 1 (1922).Google Scholar
  55. Bray, G. M., M. Kaarsoo, and R. T. Ross: Ocular myopathy with dysphagia. Neurology 15, 678 (1965).PubMedGoogle Scholar
  56. Brody, I.A.: The significance of lactate dehydrogenase isozymes in abnormal human skeletal muscle. Neurology 14, 1091 (1964).PubMedGoogle Scholar
  57. Brown, I. A., and E. M. James: Nandrolone-phenpropionate in progressive muscular dystrophy. Arch. Pediat. 78, 421 (1961).PubMedGoogle Scholar
  58. Brugsch, J., K. Brockmann-Rohne u. H. Fromm: Über Fermentveränderungen im Blute bei progressiver Muskeldystrophie. Z. ges. inn. Med. 15, 891 (1960).Google Scholar
  59. Buchthal, F.: Grundlagen und klinische Bedeutung der Elektromyographie. Verh. dtsch. Ges. inn. Med. 71, 139 (1965).PubMedGoogle Scholar
  60. Buchthal, F., og W. Trojaborg: Sporadisk optraeden af pseudohypertrofisk progressiv myopati. Nord. Med. 73, 299 (1965).Google Scholar
  61. Buscaino, G. A.: Beitrag zum Gespräch über die Therapie der progressiven Muskeldystrophie. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  62. Cao, A., A. Macciotta, G. Fiorelli, P. M. Mannucci, and G. Ideo: Chromatographie and electrophoretic pattern of lactate and malate dehydrogenase in normal human adult and foetal muscle and in muscle of patients affected by Duchenne muscular dystrophy. Enzymol. biol. clin. J. 7, 156 (1966).Google Scholar
  63. Caruso, G., and F. Buchthal: Refractory period of muscle and electromyographic findings in relatives of patients with muscular dystrophy. Brain 88, 29 (1965).PubMedCrossRefGoogle Scholar
  64. Ceroni, G. B., G. Coccagna et P. Gambetti: Un cas isolé de myopathie distale. Neuromuskuläre Erkrankungen. Berichte des 8. Internationalen Kongresses für Neurologie, TOM II, 235, Vienna 1965.Google Scholar
  65. Chung, C. S., N. E. Morton, and H. A. Peters: Serum enzymes and genetic carriers in muscular dystrophy. Amer. J. hum. Genet. 12, 52 (1960).PubMedGoogle Scholar
  66. Clayton, B. E., K. M. Wilson, and C. O. Carter: Aldolase activity in the plasma or serum of normal children and families with muscular dystrophy. Arch. Dis. Childh. 38, 208 (1963).PubMedCrossRefGoogle Scholar
  67. Clotten, R.: Aminoacidurie bei Myopathien. In: Myopathien. Hrsg. R. Beckmann. Stuttgart: Thieme 1965.Google Scholar
  68. Coirault, R., J. Levy, E. Michel-Ber, E. Mashernard, S. Desclos, De La Fonchais et F. Magingout: L’acide uridine-5-triphosphorique (TJ.T.P.) en thérapeutique. Prèsse méd. 68, 1169 (1960).Google Scholar
  69. Coleman, R. F., T. L. Munsat, C. M. Pearson, A. W. Nienhuis, L. R. Thompson, and W. J. Brown: Excerpta med. Foundation. International Congress Series No. 154, 15 (1967).Google Scholar
  70. Cooper, A. C., and J. R. Miller: Progressive muscular dystrophy: A review. Rev. canad. Biol. 21, 337 (1962).PubMedGoogle Scholar
  71. Cordier, J., A. Löwenthal, M. A. Radermecker et L. van Bogaert: Acta neurol. belg. 52, 422 (1952).Google Scholar
  72. Cumings, J. N.: Creatine and guanidoacetic acid metabolism in muscle disease. Brain 76, 299 (1953).PubMedCrossRefGoogle Scholar
  73. Danowski, T. S.: Electrolyte and endocrine studies in muscular dystrophy. Amer. J. phys. Med. 14, 281 (1955).Google Scholar
  74. Danowski, T. S., G. Sabeh, J. W. Vester, M. E. Sarver, and J. H. Sunder: Muscular dystrophy. XI Trials of 1-methyl-Δ l-androstenolone and digitoxin. Arch, intern. Med. 115, 294 (1965).Google Scholar
  75. Danowski, T. S., P. M. Wirth, M. H. Leinberger, L. A. Randall, and J. H. Peters: Muscular dystrophy. III. Serum and blood solutes and other laboratory indices. Amer. J. Dis. Child. 91, 346 (1956).Google Scholar
  76. Delord: Sur une forme de ptosis congénital et héréditaire. Presse méd. 11, 592 (1903).Google Scholar
  77. Demos, J.: Essai d’appréciation d’une action thérapeutique éventuelle au cours de la myopathie. Etude critique de l’action du p-hydroxyphenyl-butyl-amino-ethanol. Sem. Hôp. Paris 39, 572 (1963).Google Scholar
  78. Dowben, R. M.: Treatment of muscular dystrophy with steroids: a preliminary report. New Engl. J. Med. 268, 912 (1963).Google Scholar
  79. Dowben, R. M., and M. A. Perlstein: Muscular dystrophy treated with norethandrole. Arch, intern. Med. 107, 245 (1961).Google Scholar
  80. Dreifuss, F. E., and G. R. Hogan: Survival in x-chromosomal muscular dystrophy. Neurology 11, 734 (1961).PubMedGoogle Scholar
  81. Dreyfus, J. C., et G. Schapira: Glycogénolyse et phosphoglucomutase due muscle humain normal et myopathique. C. R. Soc. Biol. (Paris) 147, 1145 (1953).Google Scholar
  82. Dreyfus, J. C., et G. Schapira, F. Schapira et J. Demos: Activités enzymatiques du muscle humain. Clin. chim. Acta 1, 434 (1956).Google Scholar
  83. Dreyfus, J. C., et G. Schapira, Biochemie der progressiven Muskeldystrophie. Klin. Wsehr. 40, 373 (1962).Google Scholar
  84. Dreyfus, J. C., et G. Schapira, et G. Schapira: Biochemie et Enzymologie des Dystrophies Musculaires (Myopathies). In: Progressive Muskeldystrophie-Mvotonie-Mvasthenie. Hrsg.: E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  85. Dubois, R.. M. Graff AB et R. Ley: Forme précoce de myopathie infantile simulant la maladie de Werdnig-Hoffmann. Acta paediat. belg. 1, 1 (1946).PubMedGoogle Scholar
  86. Dubowitz, V.: Progressive muscular dystrophy of the Duchenne type in females and its mode of inheritance. Brain 83, 432 (1960).PubMedCrossRefGoogle Scholar
  87. Dubowitz, V., Treatments of muscular dystrophy. Lancet 1963 Ia, 1376.Google Scholar
  88. Dubowitz, V., Some clinical observations on childhood muscular dystrophy. Brit. J. clin. Pract. 17, 283 (1963b).Google Scholar
  89. Duchenne, G. B.: De l’Electrisation localisée et de son application à la Pathologie et à la Thérapeutique. Ed. 2. Paris: J. B. Baillière 1861.Google Scholar
  90. Duchenne, G. B., Recherches sur le paralysie musculaire pseudohypertrophique, ou paralysie myosclerosique. Arch. gén. Méd. (6 ser.) 11, 5, 179, 209, 305, 421, 552 (1868).Google Scholar
  91. Dutil, A.: Note sur une forme de ptosis congénital et hereditaire. Presse méd. 20, 401 (1892).Google Scholar
  92. Ebashi, Toyokura, Momoi, and Sugita: High creatine phosphokinase activity of sera of progressive muscular dystrophy. J. Biochem. (Tokyo) 46, 103 (1959).Google Scholar
  93. Edelschtein, E. A.: Application of new preparations in the treatment of muscular dystrophy. Zh. Nevropat. Psikhiat. 57, 856 (1957).Google Scholar
  94. Emery, A. E. H.: Clinical manifestations in two carriers of Duchenne muscular dystrophy. Lancet 19631, 1126.Google Scholar
  95. Emery, A. E. H., Electrophoretic pattern of lactic dehydrogenase in carriers and patients with Duchenne muscular dystrophy. Nature (Lond.) 201, 1044 (1964).CrossRefGoogle Scholar
  96. Emery, A. E. H., and C. S. Lee: Manifestations in carriers of x-linked muscular dystrophy. Lancet 1964II, 1066.Google Scholar
  97. Emery, A. E. H.E., Wilkinson, and E. A. Murphy: Genetic counselling in Duchenne muscular dystrophy. E. cerpta Medica Foundation. International Congress Series No. 154, 13 (1967).Google Scholar
  98. Engel, W. K.: In current concepts of myopathies. Ed. W. K. Engel. Philadelphia-Montreal: J. B. Lippincott Comp. 1965.Google Scholar
  99. Erbslöh, F., u. G. Sioli: Dystrophische Myopathien und endokrine Störungen unter besonderer Berücksichtigung des Cushing-Syndroms. Dtsch. Z. Nervenheilk. 171, 83 (1953).CrossRefGoogle Scholar
  100. Erdbringk, W. L.: Ocular myopathy associated with retinitis pigmentosa. Arch. Ophthal. 57, 335 (1957).CrossRefGoogle Scholar
  101. Eulenburg, A., u. R. Cohnheim: Ergebnisse der anatomischen Untersuchung eines Falles von sogenannter Muskelhypertrophie. Verh. Berl. Med. Ges. 1, 191 (1866).Google Scholar
  102. Ferrier, P., F. Bamatter, and D. Klein: Muscular dystrophy (Duchenne) in a girl with Turner’s syndrome. J. med. Genet. 2, 38 (1965).PubMedCrossRefGoogle Scholar
  103. Fisher, E. R., R. E. Cohn, and T. S. Danowski: Ultrastructural observations of skeletal muscle in myopathy and neuropathy with special reference to muscular dystrophy. Lab. Invest. 15, 778 (1966).PubMedGoogle Scholar
  104. Fitch, C. D., D. W. Sinton, and J. S. Dinning: J. Lab. clin. Med. 60, 874 (1962).Google Scholar
  105. Flamm, F.: Sozialmedizinische Probleme und Rehabilitation von Patienten mit Myopathien. In: Myopathien. Hrsg. R. Beckmann. Stuttgart: Thieme 1965.Google Scholar
  106. Fontaine, J. L., D. Graveleau, L. Houllemare et R. Laplane: Les Myopathies congénitales. A propos de 2 observations. Sem. Hôp. Paris 41, 415 (1965).Google Scholar
  107. Forrester, R. M.: Treatments of muscular dystrophy. Lancet 1963 II, 41.Google Scholar
  108. Fowler, W. M., and C. M. Pearson: Ineffective treatment of muscular dystrophy with an anabolic steroid. New Engl. J. Med. 272, 875 (1963).Google Scholar
  109. Georgiev, I., K. Pernov, V. Daslin e V. Jordanov: La nostra esperienza terapeutica di miopatie e di legione del sistema nervöse periferico con la nuova Bulg. Nivalina. Cultura Med. 16, 1591 (1960).Google Scholar
  110. Girdany, B., and T. S. Danowski: Muscular dystrophy: radiologic findings in relation to severity of disease. J. Dis. Child. 91, 339 (1956).Google Scholar
  111. Gospavić, H., U. J. Peleksic: Ein Beitrag zur Semiologie der progressiven Muskeldystrophie. Berichte des 8. Internationalen Kongresses für Neurologie. TOM II, 211, Vienna 1965.Google Scholar
  112. Gowers, W. R.: Pseudo-Hypertrophic muscular paralysis: A clinical lecture. London: Churchill 1879.Google Scholar
  113. de Grouchy, J., M. Lamy, J. Frezal et R. Garcin: Etude d’un couple de jumeaux monozygotes dont un seul est atteint de myopathie (Forme pseudo-hypertrophique). Acta Genet, med. (Roma) 4, 324 (1963).Google Scholar
  114. Grüneberg, H.: Die Wirkungsweise von Genen in X-Chromosomen von Säugern. Humangenetik 5, 83 (1968).PubMedCrossRefGoogle Scholar
  115. Hallen, O.: Augenmuskellähmungen in neurologischer Sicht. Dtsch. Z. Nervenheilk. 187, 455 (1965).CrossRefGoogle Scholar
  116. Hallen, O., Über die Dystrophia ossea und andere Skelettveränderungen bei der Dystrophia musculorum progressiva. 8. Int. Kongr. Neurol. TOM II, Vienna 1965.Google Scholar
  117. Hantschmann, N., D. Matzelt, H. G. Mertens U. H. Nowakowski: Zur Behandlung von Muskelkrankheiten mit anabolen Steroiden. Dtsch. med. Wschr. 87, 2619 (1962).CrossRefGoogle Scholar
  118. Harris, P. L., and K. E. Mason: Alpha-toco-hydroquinone and muscle dystrophy. Amer. J. clin. Nutr. 4, 402 (1956).PubMedGoogle Scholar
  119. Hausmanowa-Petrttsewicz, J., J. Prot, J. Niebroj-Dobocz, B. Emeryk, B. Wasowicz, C. Slucka, L. Hetnarska, B. Banarzweska, and Z. Pucek: Investigation of healthy relatives of patients with Duchenne type dystrophy. 8. Internat. Kongr. f. Neurologie TOM II, Vienna 1965.Google Scholar
  120. Heyck, H.: Gespräch über die Therapie der progressiven Muskeldystrophie. Leitung: R. Beckmann. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966Google Scholar
  121. Heyck, H., u. G. Laudahn: III. Enzymaktivitätsänderungen im Serum bei Dystrophia musculorum progressiva. Klin. Wschr. 41, 905 (1963).CrossRefGoogle Scholar
  122. Heyck, H., u. G. Laudahn, u. C. Lüders: Enzymaktivitätsänderungen im Muskel bei Dystrophia musculorum progressiva. Klin. Wschr. 41, 500 (1963).PubMedCrossRefGoogle Scholar
  123. Horvath, B.: Neurology 8, Suppl. 1, 52 (1958).Google Scholar
  124. Horvath, B., L. Berg, D. J. Cummings, and G. M. Shy: Muscular dystrophy. Cation concentrations in residual muscle. J. appl. Physiol. 8, 22 (1955).PubMedGoogle Scholar
  125. Hottinger, A., u. H. Berger: Freie alpha-Aminosäuren in Serum und Urin bei progressiver Muskeldystrophie (Eine Familienuntersuchung). In: Myopathien. Hrsg. R. Beckmann. Stuttgart: Thieme 1965.Google Scholar
  126. Hughes, B. P.: Serum enzymes in carriers of muscular dystrophy. Brit. med. J. 1962II, 963.Google Scholar
  127. Huvos, A. G., and W. Pruzanski: Smooth muscle involvement in primary muscle disease II. Progressive muscular dystrophy. Arch. Path. 83, 234 (1967).PubMedGoogle Scholar
  128. Irwin, R. L., and M. M. Hein: Ionic requirements for relaxation of slow striated muscle. Amer. J. Physiol. 211, 1117 (1966).PubMedGoogle Scholar
  129. Jackson, Ch. E., W. D. Block, and A. Arbor: Serum electrophoretic studies of patients with a recessively inherited muscular dystrophy. J. Lab. clin. Med. 48, 820 (1956).Google Scholar
  130. Jackson, E. E., and J. H. Carey: Progressive muscular dystrophy: autosomal recessive type. Pediatrics 28, 77 (1961).PubMedGoogle Scholar
  131. Jacobs, J.: Laevadosin in muscular dystrophy. Brit. med. J. 1965II, 704.Google Scholar
  132. Jakob, W., U. J. Neuhaus: Die Aktivität der Serumaldolase bei der progressiven Muskeldystrophie (Erb). Klin. Wschr. 32, 923 (1954).CrossRefGoogle Scholar
  133. Johnston, H. A.: Severe muscular dystrophy in girls. J. Med. Genet. 1, 79 (1964).PubMedCrossRefGoogle Scholar
  134. Kaeser, H. E.: Das Verhalten der Serum-Glutaminsäure-Oxalessigsäure-Transaminase bei Myopathien und neurogenen Muskelatrophien. Dtsch. Z. Nervenheilk. 179, 353 (1959).CrossRefGoogle Scholar
  135. Kaeser, H. E., Serum-Transaminasebestimmungen bei der progressiven Muskeldystrophie mit besonderer Berücksichtigung der Untergruppen von Becker. Ann. paediat. (Basel) 195, 1 (1960).Google Scholar
  136. Kar, N. C., and C. M. Pearson: Glutamic oxalacetic transaminase isoenzymes in human myopathies. Proc. Soc. exp. Biol. (N. Y.) 116, 733 (1964).Google Scholar
  137. Kar, N. C., and C. M. Pearson, Creatine phosphokinase isoenzymes in muscle in human myopathies. Amer. J. clin. Path. 43, 207 (1965).Google Scholar
  138. Karpati, G., and W. K. Engel: Histochemical study of skeletal muscle in carriers of Duchenne dystrophy. Excerpta Medica Foundation. International Congress Series Nr. 154, 15 (1967).Google Scholar
  139. Kelly, S., W. D. Kelly, and H. L. Swift: Serum creatine phosphokinase in 4 generations of a muscular dystrophy family. Amer. J. clin. Path. 45, 377 (1966).Google Scholar
  140. Keuth, U.: Beitrag zur klinischen Diagnostik der Herzbeteiligung bei der progressiven Muskeldystrophie. Z. Kinderheilk. 84, 617 (1960).PubMedCrossRefGoogle Scholar
  141. Kiloh, L. G., and S. Nevin: Progressive dystrophy of the external ocular muscles (Ocular myopathy). Brain 74, 115 (1951).PubMedCrossRefGoogle Scholar
  142. Klatzo, I., B. Horvath, and W. K. Engel: Observations on myosin in the abnormal muscle using fluorescent antibody technique. Proc. Ass. Res. Nerv. Mental Dis. 38, 730 (1960).Google Scholar
  143. Kloepfer, H. W., and C. Talley: Autosomal recessiv inheritance of Duchenne-type muscular dystrophy. Acta genet. (Basel) 7, 314 (1957).Google Scholar
  144. Kossmann, R. J., D. C. Peterson, and H. L. Andrews: Studies in neuromuscular disease: I. Total body potassium in muscular dystrophy and related disease. Neurology (Minneap.) 15, 855 (1965).Google Scholar
  145. Kunze, D., D. Olthoff u. K. Schellnack: Die Phosphatide der Skelettmuskulatur bei progressiver Muskeldystrophie — eine Untersuchung an Muskelbiopsieproben. Acta biol. med. germ. 19, 1057 (1967).PubMedGoogle Scholar
  146. Kurland, L. T.: Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota. J. chron. Dis. 8, 378 (1958).PubMedCrossRefGoogle Scholar
  147. Laudahn, G.: Zur Biochemie der Progressiven Muskeldystrophie. Vergleichende enzymatische Untersuchungen in Skelettmuskulatur, Serum und Vollblut von Gesunden und Patienten mit progressiver Muskeldystrophie. Fortschr. Med. 84, 429 (1966).Google Scholar
  148. Laudahn, G., u. H. Heyck: Feraientakdvitätsbestimmungen in der gesunden menschlichen Muskulatur und bei Myopathien. I. Mitteilung. Enzymmuster und intracellulare Verteilung von Enzymen im gesunden Skelettmuskel. Klin. Wschr. 41, 493 (1963).CrossRefGoogle Scholar
  149. Laird, J. L., and R. F. Timmer: Transplantation of skeletal muscle into a host with muscular dystrophy. Tex. Rep. Biol. Med. 24, 169 (1966).PubMedGoogle Scholar
  150. Lamy, M., et J. de Grouchy: L’héridité de la myopathie (formes basses). J. Génét. hum. 3, 219 (1954).Google Scholar
  151. Landouzy, L., et J. Déjérine: De la myopathie atrophique progressive (myopathie sans neuropathie, debutant d’ordinaire dans l’enfance, par la face). Rev. Méd. 5, 8, 253 (1885).Google Scholar
  152. Landouzy, L., et J. Déjérine, Nouvelles recherches cliniques et anatome-pathologiques sur la myopathie atrophique progressive a propos de six observations nouvelles, dont une avec autopsie. Rev. Méd. 6, 977 (1886).Google Scholar
  153. Levison, H.: Dystrophia musculorum progressiva. Copenhagen: Munksgaard 1951.Google Scholar
  154. Lewis, A. J., and D. F. Besant: Muscular dystrophy in infancy. J. Pediat. 60, 376 (1962).PubMedCrossRefGoogle Scholar
  155. Lewis, A. J., Late-onset muscle dystrophy: Oculopharyngoesophageal variety. Canad. med. Ass. J. 95, 146 (1966).Google Scholar
  156. Leyburn, P., W.H. S. Thomson, and J. N. Walton: An investigation of the carrier state in the Duchenne type muscular dystrophy. Ann. hum. Genet. 25, 41 (1961).PubMedCrossRefGoogle Scholar
  157. Lichtigfeld, F. J.: Treatment of muscular dystrophy. Lancet 1963II, 41.Google Scholar
  158. Lichtheim: Progressive Muskelatrophie ohne Erkrankung der grauen Vorderhörner des Rückenmarks. Arch. Psychiat. Nervenkr. 8, (1878).Google Scholar
  159. Lombardo, G., and G. Orena: Minerva pediat. 14, 724 (1962).PubMedGoogle Scholar
  160. Ludwig, O., u. I. Warlamidis: Myokardläsion bei Dystrophia musculorum progressiva Erb. Wien. med. Wschr. 117, 271 (1967).PubMedGoogle Scholar
  161. Luzzatto, A., e E. Lodigiani: Reperto di iperpiruvicemia nella distrofia muscolare progressiva. Minerva med. 45, 725 (1954).PubMedGoogle Scholar
  162. Luzzatto, A., e E. Ramelli: L’iperpiruvicemia nella distrofia muscolare progressiva è una caratteristica genica? Cervello 35, 377 (1959).Google Scholar
  163. Lyon, M. F.: Gene action in the x-chromosoms of the mouse (Mus musculus L.). Nature (Lond.) 190, 372 (1961).CrossRefGoogle Scholar
  164. Lyon, M. F., Sex chromatin and gene action in the mammalian x-chromosome. Amer. J. hum. Genet. 14. 135 (1962).PubMedGoogle Scholar
  165. Mabry, C., I. E. Roeckel, R. L. Munich, and D. Robertson: X-linked pseudohypertrophic muscular dystrophy with a late onset and slow progression. New Engl. J. Med. 20, 1062 (1965)Google Scholar
  166. Mcardle, B.: Biochemical findings in neuro-muscular disorders. Berichte des 8. Internationalen Kongresses für Neurologie TOM II, Vienna 1965.Google Scholar
  167. Magee, K. R., and R. N. De Jong: Distal myopathy with onset in infancy. Berichte des 8. Internationalen Kongresses für Neurologie, TOM II 245, Vienna 1965.Google Scholar
  168. Mahloudji, M.: Muscular dystrophy with distal involvement and other unusual features. Berichte des 8. Internationalen Kongresses für Neurologie TOM II, 229, Vienna 1965.Google Scholar
  169. Manning, G. W., and G. J. Cropp: The electrocardiogram in progressive muscular dystrophy. Brit. Heart J. 20, 416 (1958).PubMedCrossRefGoogle Scholar
  170. Menne, F., u. R. Beckmann: Der Kreatinstoffwechsel bei Kindern mit Dystrophia musculorum progressiva Erb. Klin. Wschr. 33, 556 (1955).PubMedCrossRefGoogle Scholar
  171. Mertens, H. G.: Beitrag zum Gespräch über Therapie der progressiven Muskeldystrophie. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  172. Mertens, H. G., B. Möbius u. J. Möbius: Die Differentialdiagnose der Muskeldystrophien. Internist 7, 175 (1966).PubMedGoogle Scholar
  173. Meryen, E.: On granular and fatty degeneration of voluntary muscles. Med. Chir. Trans. 35, 73 (1857).Google Scholar
  174. Milhorat, A. T.: Therapy in muscular dystrophy. Med. Ann. D.C. 23, 15 (1954).Google Scholar
  175. Milhorat, A. T., Report on the therapeutic trial of methenolone (l-methyl-Δ1-androstenolone) in muscular dystrophy, Sept. 3.–4. (1964). Biennial chapter Conference of the Muscular Dystrophy Associations of America.Google Scholar
  176. Milhorat, A. T., and H. G. Wolff: Studies in diseases of muscle. I. Metabolism of creatine and creatinine in progressive muscular dystrophy. Arch. Neurol. Psychiat. 38, 992 (1937).Google Scholar
  177. Milhorat, A. T., and H. G. Wolff, Studies in diseases of muscle. XII. Heredity of progressive muscular dystrophy. Arch. Neurol. Psychiat. 49, 641 (1943).Google Scholar
  178. Milhorat, A. T., L. Goldstone, and A. Kibrick: Observations on effect of chromanol of hexahydrocoenzyme Q4 in muscular dystrophy. In: Exploratory concepts in muscular dystrophy and related disorders. Amsterdam-New York-London: Excerpta Medica Foundations 1967.Google Scholar
  179. Milhorat, A. T., A. S. Shafig, and L. Goldstone: Changes in muscle structur in dystrophic patients, carriers and normal siblings seen by electron microscopy; correlation with levels of serum creatine phosphokinase (CPK). Ann. N. Y. Acad. Sci. 138, 246 (1966).PubMedCrossRefGoogle Scholar
  180. Minot, A. S., H. Frank, and D. Dziewiatkowski: The occurrence of pentose- and phosphorus-containing complexes in the urine of patients with progressive muscular dystrophy. Arch. Biochem. 20, 394 (1949).PubMedGoogle Scholar
  181. Miyoshi, K., K. Saijo, Y. Kuryu, and Y. Oshima: Abnormal myoglobin ultraviolet spectrum in Duchenne type of progressive muscular dystrophy. Science 142, 490 (1963).PubMedCrossRefGoogle Scholar
  182. Mölbert, E.: Das elektronenmikroskopische Bild des Skelettmuskels bei Dystrophia musculorum progressiva Erb. Naturwissenschaften 47, 186 (1960).CrossRefGoogle Scholar
  183. Monckton, G., and B. Ludvigsen: The identification of carriers in Duchenne muscular dystrophy. Canad. med. Ass. J. 89, 333 (1963).Google Scholar
  184. Morscher, E.: Orthopädische Maßnahmen bei Muskeldystrophie und anderen Myopathien. in: Myopathien. Hrsg. R. Beckmann. Stuttgart: Thieme 1965.Google Scholar
  185. Morton, N. E., and C. S. Chung: Formal genetics of muscular dystrophy. Amer. J. hum. Genet. 11, 360 (1959).PubMedGoogle Scholar
  186. Moser, H., U. Wiesmann, R. Richterich u. E. Rossi: Progressive Muskeldystrophie VIII. Häufigkeit, Klinik und Genetik der Typen I und II. Schweiz, med. Wschr. 96, 169 (1966).Google Scholar
  187. Moser, H., U. Wiesmann, R. Richterich u. E. Rossi, Progressive Muskeldystrophie VIII. Häufigkeit, Klinik und Genetik der Typen I und II (Schluß). Schweiz, med. Wschr. 96, 205 (1966).Google Scholar
  188. Moser, H., U. Wiesmann, R. Richterich u. E. Rossi, Progressive Muskeldystrophie. VI. Häufigkeit, Klinik und Genetik der Duchenne Form. Schweiz, med. Wschr. 94, 1610 (1964).Google Scholar
  189. Mumenthaler, M.: Die histologische Diagnostik der progressiven Muskeldystrophie. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966Google Scholar
  190. Mumenthaler, M., T. Bosch, E. Katzenstein u. F. Lehner: Über den isolierten Befall des M. Quadriceps femoris bei der Dystrophia musculorum progressiva. Confin. neurol. (Chic.) 18, 416 (1958).CrossRefGoogle Scholar
  191. Nakahara, M.: Studies on progressive muscular dystrophy. Arzneimittel-Forsch. 15, 591 (1965).Google Scholar
  192. Nichol, C. J.: Serum creatine phosphokinase measurements in muscular dystrophy studies. Clin. chim. Acta 1965II, 404.Google Scholar
  193. Niebrój-Dobosz, I.: Disturbance of the combustion processes in muscular disorders. J. Neurol. Neurosurg. Psychiat. 28, 19 (1965).PubMedCrossRefGoogle Scholar
  194. Niebrój-Dobosz, I., u. I. Hattsmanowa-Petrusewicz: The potassium level in dystrophic muscles. Neurol. Neurochir. Psychiat. pol. 13, 748 (1963).Google Scholar
  195. Niebrój-Dobosz, I., u. I. Hattsmanowa-Petrusewicz, Protein, lipoprotein and glycoprotein fractions of blood serum in muscle diseases. Pol. med. J. 1968III, 689.Google Scholar
  196. Norris, F. H., A. J. Moss, and P. N. Yu: On the possibility that a type of human muscular dystrophy commences in myocardium. Ann. N. Y. Acad. Sci. 138, 342 (1966).PubMedCrossRefGoogle Scholar
  197. Okinaka, S.: Serum creatine phosphokinase. Arch. Neurol. Psychiat. (Chic.) 4, 520 (1961).CrossRefGoogle Scholar
  198. Okinaka, S., H. Sugita, H. Momoi, Y. Toyokura, H. Kumagai, S. Ebashi, and Y. Fujie: Serum creatine phosphokinase and aldolase activity in neuromuscular disorders. Trans. Amer. Neurol. Ass. 84, 62 (1959).PubMedGoogle Scholar
  199. Oppenheimer, H., and A. T. Milhorat: Serum proteins, lipoproteins and glycoproteins in muscular dystrophy and related diseases. Ann. N. Y. Acad. Sci. 94, 308 (1961).PubMedCrossRefGoogle Scholar
  200. Oppenheimer, H., K. Barany, H. Terry, and E. Forsyth: Molecular weight and size of myosin from mice with hereditary muscular dystrophy. Fed. Proc. 20, 299 (1961).Google Scholar
  201. Palazzuoli, M., e A. Parrini: Amiotrofia cheiro-faciale unilaterale eredofamiliale. Riv. Pat. nerv. ment. 79, 977 (1958).Google Scholar
  202. Pansini, R.: Ricerche sulla fisiopatologia muscolare delTumo. Comportamento dell’alcoolemia, piruvicemia e glicemia nel circolo venoso superificiale dopo carico d’insulina in miöpatici. Rass. Fisiopat. clin. ter. 25, 421 (1953).PubMedGoogle Scholar
  203. Partridge: Fatty degeneration of voluntary muscles. Trans, path. Soc. Lond. 1, 334 (1846).Google Scholar
  204. Pateisky, K., H. Schinko, and H. Haberler: A study of the treatment of dystrophia musculorum progressiva with an anabolic steroid: norandrostenolone decanoate. Acta endocr. (Kbh.) 39 (Suppl. 63), 185 (1961).Google Scholar
  205. Pearce, J. M. S., S. S. Gubbay, J. Hardy, R. J. T. Pennington, D. J. Newell, and J. N. Walton: Laevadosin in treatment of the Duchenne type of muscular dystrophy: Preliminary results of a double-blind controlled trial. Brit. med. J. 1964II, 915.Google Scholar
  206. Pearce, J. M. S., J. M. S. Pearce, and J. N. Walton: The Duchenne type muscular dystrophy: Histo- pathological studies of the carrier state. Brain 89, 109 (1966).PubMedCrossRefGoogle Scholar
  207. Pearson, C. M.: Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. New Engl. J. Med. 256, 1096 (1957).Google Scholar
  208. Pearson, C. M., Histopathological features of muscle in the preclinical stages of muscular dvstrophv. Brain 85. 109 (1962).PubMedCrossRefGoogle Scholar
  209. Pearson, C. M., and W. G. Fowler: Hereditary non-progressive muscular dystrophy inducing arthrogryposis syndrome. Brain 86, 75 (1963).PubMedCrossRefGoogle Scholar
  210. Pearson, C. M., W. G. Fowler, and S. W. Wright: x-chromosome mosaicisme in females with muscular dystrophy. Proc. nat. Acad. Sci. (Wash.) 50, 24 (1963).CrossRefGoogle Scholar
  211. Pearson, C. M., N. C. Kar, J. B. Peter, and T. L. Munsat: Muscle lactate dehydrogenase patterns in two types of x-linked muscular dystrophy. Amer. J. Med. 39, 91 (1965).PubMedCrossRefGoogle Scholar
  212. Pearson, C. M., Differential diagnosis of neuromuscular disease by clinical evaluation. Arch. phys. Med. 47, 122 (1966).Google Scholar
  213. Pereyra Käfer, J., G. F. Poch y L. Tamaroff: Contribution casuistica a la genetica de los distrofias musculares. Rev. neurol. B. Aires 15, 161 (1957).Google Scholar
  214. Perkoff, G. T.: Studies of human myoglobin in several diseases of muscle. New Engl. J. Med. 270, 263 (1964).Google Scholar
  215. Perkoff, G. T., D. M. Brown, and F. H. Tyler: The isolation of myoglobin in progressive muscular dystrophy. J. clin. Endocr. 17, 1489 (1957).PubMedCrossRefGoogle Scholar
  216. Perloff, J. K., A. C. de Leon, Jr., and D. O’Doherty: The cardiomyopathy of progressive muscular dystrophy. Circulation 33, 625 (1966).PubMedGoogle Scholar
  217. Perlstein, M. A.: Deep-tendon reflexes in pseudohypertrophic muscular dystrophy. J. Amer. med. Ass. 193, 202 (1965).CrossRefGoogle Scholar
  218. Radu, H., J. Gödri, G. Blücher, S. Migea u. L. Bordeianu: 32P-Stoffwechselstudie bei Muskelkrankheiten verschiedener Genese. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  219. Radu, H., K. Stenzel, S. Migea u. L. Bordeianu: Behandlung von Muskeldystrophien mit dem Nucleosid-Nudleotid-Gemisch Laevadosin. Münch. Med. Wschr. 109, 2702 (1967).Google Scholar
  220. Richterich, R.: Zur Biochemie der progressiven Muskeldystrophie. In: Myopathien. Hrsg. R. Beckmann. Stuttgart: Thieme 1965.Google Scholar
  221. Richterich, R., E. Gautier, W. Egli, K. Zuppinger u. E. Rossi: Progressive Muskeldystrophie. I. Mitteilung. Die Heterogenität der Serum-Lactat-Dehydrogenase. Klin. Wschr. 39, 346 (1961).PubMedCrossRefGoogle Scholar
  222. Richterich, R., S. Rosin, U. Aebi, and E. Rossi: Progressive muscular dystrophy. V. The identification of the carrier state in the Duchenne type by serum creatine kinase determination. Amer. J. hum. Genet. 15, 133 (1963).Google Scholar
  223. Rossi, E.: Gespräch über die Therapie der progressiven Muskeldystrophie. Leitung R. Beckmann. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  224. Rotthauwe, H. W., u. S. Kowalewski: Klinische und biochemische Untersuchungen bei Myopathien. I. Mitteilung. Serumenzyme bei progressiver Muskeldystrophie (Typ I, II, Ilia). Klin. Wschr. 43, 144 (1965).Google Scholar
  225. Rotthauwe, H. W., u. S. Kowalewski, Gutartige recessiv x-chromosomal vererbte Muskeldystrophie. I. Untersuchungen bei Merkmalsträgern. Humangenetik 3, 17 (1966).PubMedCrossRefGoogle Scholar
  226. Rowland, L. P., and G. Ross: Serum aldolase in muscular dystrophies, neuromuscular disorders, and wasting of skeletal muscle. Arch. Neurol. Psychiat. (Chic.) 80, 157 (1958).Google Scholar
  227. Rowland, L. P., P. B. Dunne, A. S. Penn, and E. Maher: Myoglobin and muscular dystrophy. Arch. Neurol. (Chic.) 18, 141 (1968).CrossRefGoogle Scholar
  228. Rubin, I. L., and A. S. Buchberg: The heart in progressive muscular dystrophy. Amer. Heart J. 43, 161 (1952).PubMedCrossRefGoogle Scholar
  229. Russe, H., H. Busey, and A. Barbeau: Immunoglobulin changes in oculopharyngeal muscular dystrophy. Excerpta Medica Foundation. Internal Congress Series No. 154, 11–12 (1967).Google Scholar
  230. Schapira, G., J. C. Dreyfus et F. Schapira: L’élévation du taux de l’aldolase sérique test biochimique des myopathies. Sem. Hop. Paris 29, 191 (1953).Google Scholar
  231. Schapira, G., M. Joly et J. C. Dreyfus: C. R. Soc. Biol. (Paris) 148, 1056 (1954).Google Scholar
  232. Schapira, J., J. C. Dreyfus, F. Schapira, and J. Kruh: Glycogenolytic enzymes in human progressive muscular dystrophy. Amer. J. phys. Med. 34, 313 (1955).PubMedGoogle Scholar
  233. Schapira, F., J. C. Dreyfus, G. Schapira et J. Demos: Etude de l’aldolase et de la créatine kinase du sérum chez les mères de myopathes. Rev. franc. Etud. clin. biol. 5, 990 (1960).Google Scholar
  234. Schönenberg, H.: Papierchromatographische Untersuchungen bei der Dystrophia musculorum progressiva sowie anderen Myopathien. Klin. Wschr. 33, 513 (1955).PubMedCrossRefGoogle Scholar
  235. Schott, J., M. Jacobi, and M. A. Wald: Electrocardiographic patterns in the differential diagnosis of progressive muscular dystrophy. Amer. J. med. Sci. 229, 517 (1955).PubMedCrossRefGoogle Scholar
  236. Schultze, F.: Über den mit Hypertrophie verbundenen progressiven Muskelschwund und ähnliche Krankheitsformen. Wiesbaden: J. F. Bergmann 1886.Google Scholar
  237. Seitz, D.: Die Bedeutung der Muskelbiopsie für die Diagnose und Therapie chronischer neuromuskulärer Prozesse. Habilitationsschrift, Hamburg (1963).Google Scholar
  238. Serre, H., et M. Temple: Myopathie à forme lombo-pelvifemorale de l’adulte avec Osteoporose rachidienne. Montpellier méd. 52, 104 (1957).Google Scholar
  239. Shaw, R. F., C. M. Pearson, and S. R. Chowdhury and F. E. Dreifuss: Serum enzymes in sex-linked (Duchenne) muscular dystrophy. Arch. Neurol. (Chic.) 16, 115 (1967).CrossRefGoogle Scholar
  240. Sherwin, A. C., and R. S. McCully: Reactions observed in boys of various ages to a crippling, progressive and fatal illness (muscular dystrophy). J. chron. Dis. 13, 59 (1961).CrossRefGoogle Scholar
  241. Shy, G. M., D. J. Cummings, L. Berg, and B. Horvath: Muscular dystrophy. Potassium exchange in residual muscle. J. appl. Physiol. 8, 33 (1955/56).Google Scholar
  242. Sibley, J. A., and A. L. Lehninger: Aldolase in the serum and tissues of tumor-bearing animals. J. nat. Cancer Inst. 9, 303 (1959).Google Scholar
  243. Sidler, A.: Beitrag zur Vererbung der progressiven Muskeldystrophy. Arch. Klaus-Stift. Vererb.-Forsch. 19, 213 (1944).Google Scholar
  244. Siekert, R. G., and G. A. Fleisher: Serum glutamic oxalacetic transaminase in certain neurologic and neuromuscular diseases. Proc. Mayo Clin. 31, 459 (1956).Google Scholar
  245. Sjövall, B.: Dystrophia musculorum progressiva. Copenhagen: Levin & Munksgaard 1936.Google Scholar
  246. Skying, A., and V. A. McKusick: Clinical, genetic and electrocardiographic studies in childhood muscular dystrophy. Amer. J. med. Sci. N. S. 242, 534 (1961).CrossRefGoogle Scholar
  247. Smith, C. A. B.: Colour blindness and the Duchenne-type muscular dystrophy. Ann. hum. Genet. 21, 155 (1956/57).Google Scholar
  248. Smith, H. L., R. L. Fischer, and J. N. Etteldorf: Magnesium and calcium in human muscular dystrophy. Amer. J. Dis. Child. 103, 771 (1962).PubMedGoogle Scholar
  249. Soltan, H. C.: Muscular dystrophy in three pairs of twins. Acta Genet, med. (Roma) 8, 434 (1959).Google Scholar
  250. Soltan, H. C., and M. C. Blanchaer: Activity of serum aldolase and lactic dehydrogenase in patients affected with Duchenne muscular dystrophy and in their immediate relatives. J. Pediat. 54, 27 (1959).PubMedCrossRefGoogle Scholar
  251. Stelgens, P.: Über die Behandlung der Dystrophia musculorum progressiva (Erb) mit Adenosintriphosphorsäure. Dtsch. med. Wschr. 82, 1761 (1957).CrossRefGoogle Scholar
  252. Stephens, F. E., and F. H. Tyler: Studies in disorder of muscle. V. The inheritance of childhood progressive muscular dystrophy in 33 kindreds. Amer. J. hum. Genet. 3, 111 (1951).Google Scholar
  253. Stephens, J., M. L. Hoover, and J. Denst: On familial ataxie, neural amyotrophy and their association with progressive external ophthalmoplegia. Brain 81, 556 (1958).PubMedCrossRefGoogle Scholar
  254. Stephens, J., and E. Lewin: Serum enzyme variations and histological abnormalities in the carrier state in Duchenne dystrophy. J. Neurol. Neurosurg. Psychiat. 28, 104 (1965).PubMedCrossRefGoogle Scholar
  255. Stevenson, A. C.: Muscular dystrophy in Northern Ireland. I. An account of the condition in fifty-one families. Ann. Eugen. (Lond.) 18, 50 (1953).Google Scholar
  256. Stewart, J. S. S., and A. R. Sanderson: Sex-chromatin body in normal human testis. Lancet 1961I, 79.Google Scholar
  257. Storstein, O.: The heart in progressive muscular dystrophy. Exp. Med. Surg. 22, 13 (1964).PubMedGoogle Scholar
  258. Stroinska-Kusiowa, B.: Radiologische Veränderungen der langen Röhrenknochen bei Dystrophia musculorum progressiva. 8. Internationaler Kongress Neurologie, Berichte TOM II, 265 Vienna 1965.Google Scholar
  259. Struppler, A.: In: Bodechtel, G.: Differentialdiagnose neurologischer Krankheitsbilder. Stuttgart: Thieme 1963.Google Scholar
  260. Sugita, H.: Clinical and experimental investigations on creatine phosphokinase and aldolase activity in neuromuscular disorders. Psychiat. Neurol, jap. 62, 106 (1960).Google Scholar
  261. Sugita, H., and F. H. Tyler: Pathogenesis of muscular dystrophy. Trans. Ass. Amer. Phys. 76, 231 (1963).Google Scholar
  262. Sugita, H., and S. Ebashi: Detection of carriers of Duchenne type DMP by 86 Rb. Exerpta Medica Foundation. International Congress Series No. 154, 16 (1967).Google Scholar
  263. Sundermeyer, J. F., S. Gudbjarnason, V. E. Wendt, P. B. den Bakkar, and R. J. Bing: Myocardial metabolism in progressive muscular dystrophy. Circulation 24, 1348 (1961).PubMedGoogle Scholar
  264. Swaiman, K. F., and B. Sandler: The use of Serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy. Pediatrics 63, 1116 (1963).CrossRefGoogle Scholar
  265. Swinyard, C. A., G. G. Deaver, and L. Greenspan: Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch. phys. Med. 38, 574 (1957).Google Scholar
  266. Tada, K., H. Hirono, and H. Miyazawa: Oxygen consumption and anaerobic glycolysis of the muscle from the patients with progressive muscular dystrophy. Tohoku J. exp. Med. 79 135 (1963).Google Scholar
  267. Tappel, A. L., H. Zalkin, K. A. Caldwell, I. D. Desai, and S. Shibko: Arch. Biochem. 96, 340 (1962).PubMedCrossRefGoogle Scholar
  268. Taylor, E. W.: Progressive vagus-glossopharyngeal paralysis with ptosis. A contribution to the group of family diseases. J. nerv. ment. Dis. 42, 129 (1915).CrossRefGoogle Scholar
  269. Teasdall, R. D., and M. L. Sears: Ocular myopathy. Clinical and electromyographic con-siderations. Arch. Neurol. 1960II, 281.Google Scholar
  270. Thomson, M. W., B. Ludvigsen, and G. Monckton: Some problems in genetics of muscular dystrophy. Rev. canad. Biol. 21, 543 (1962).Google Scholar
  271. Thomson, W. H. S.: The clinical biochemist rv of the muscular dvstrophv. Ad vane. clin. Chem. 7. 137 (1964).Google Scholar
  272. Thomson, W. H. S., and K.E. Guest: A trial of therapie by nucleosides and nucleotides in muscular dystrophv. J. Neurol. Neurosurg. Psychiat. 26, 111 (1963).PubMedCrossRefGoogle Scholar
  273. Thomson, W. H. S., and K.E. Guest, A trial of therapie by nucleosides and nucleotides. In: Myopathien. Hrsg. R. Beckmann. Stuttgart: Thieme 1965.Google Scholar
  274. Thomson, W. H. S., P. Leyburn, and J. N. Walton: Serum enzyme activity in muscular dystrophies. Brit, med. J. 1960, 1270.Google Scholar
  275. Tilscher, H., U. S. Schenk: Neue Aspekte der Behandlung der progressiven Muskeldystrophie. Wien. med. Wschr. 117, 1000 (1967).Google Scholar
  276. De Toni, E.: Treatment of progressive muscular dystrophy in particular with the anabolic steroids. Acta endocr. (Kbh.) 39 (Suppl. 63), 175 (1961).Google Scholar
  277. Tyler, F. H., and G. T. Perkoff: Studies in disorders of muscle. VI. Is progressive muscular dystrophy an endocrine or metabolic disorder ? Arch, intern. Med. 88, 175 (1951).CrossRefGoogle Scholar
  278. Vasella, F., R. Richterich, and E. Rossi: The diagnostic value of serum creatine kinase in neuromuscular and muscular disease. Pediatrics 35, 322 (1965).Google Scholar
  279. Victor, M., R. Hayes, and R. D. Adams: Oculopharyngeal muscular dystrophy. A familial disease of late life characterised by dysphagia and progressive ptosis of the eyelids. New Engl. J. Med. 267, 1267 (1962).Google Scholar
  280. Vignos, P. J. jr., and M. Lefkowitz: A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy. J. clin. Invest. 38, 873 (1959).Google Scholar
  281. Vignos, P. J. jr., and J. L. Warner: Glycogen, creatine, and high energy phosphate in human muscle disease. J. Lab. clin. Med. 62, 579 (1963).Google Scholar
  282. Vignos, P. J. jr., G. E. Spencer, and K. C. Archibald: Management of progressive muscular dystrophy of childhood. J. Amer. med. Ass. 184, 89 (1963).Google Scholar
  283. Vignos, P. J. jr., and M. P. Watkins: The effect of exercise in muscular dystrophy. J. Amer. med. Ass. 197, 843 (1966).Google Scholar
  284. Walton, J. N.: On the inheritance of muscular dystrophy. Ann. hum. Genet. 20, 1 (1955).PubMedCrossRefGoogle Scholar
  285. Walton, J. N., Two cases of myopathy limited to the quadriceps. J. Neurol. Neurosurg. Psychiat. 19, 106 (1956).PubMedCrossRefGoogle Scholar
  286. Walton, J. N., The inheritance of muscular dystrophy. Acta genet. (Basel) 7, 318 (1957).Google Scholar
  287. Walton, J. N.: In: Muscular dystrophy in man and animals. Ed. Bourne, G. H., and M. N. Golarz. Basel: Karger 1963.Google Scholar
  288. Walton, J. N., Some clinical and genetic aspects of the muscular dystrophies, Some clinical and genetic aspects of the muscular dystrophies. “Muscle”, Proceedings of the symposium held at the Faculty of Medicine, University of Alberta, June 1–4, 1964.Google Scholar
  289. Walton, J. N., Muscular dystrophy: Some recent advances in knowledge. Brit. med. J. 1964I, 1271.Google Scholar
  290. Walton, J. N., Muscular dystrophy: Some recent advances in knowledge. Brit. med. J. 1964I, 1344.Google Scholar
  291. Walton, J. N., Current research in muscular dystrophy. A muscular dystrophy group symposium. Develop. Med. Child. Neurol. 7, 205 (1965).CrossRefGoogle Scholar
  292. Walton, J. N., D. Gardner-Medwin, and P. Hudgson: Carrier detection in the Duchenne type muscular dystrophy. Excerpta Medica Foundation, International Congress Series No. 154, 14 (1967).Google Scholar
  293. Walton, J. N., and F. J. Nattrass: On the classification, natural history and treatment of the myopathies. Brain 77, 169 (1954).PubMedCrossRefGoogle Scholar
  294. Weisenfeld, S., and W. J. Messinger: Cardiac involvement in progressive muscular dystrophy. Amer. Heart J. 43, 170 (1952).PubMedCrossRefGoogle Scholar
  295. Welander, L.: Myopathia distalis tarda hereditaria 249 examined cases, in 72 pedigrees. Acta med. scand. 141, Suppl. 265 (1951).Google Scholar
  296. Welsh, J. D., T. N. Lynn, and G. R. Haase: Cardiac findings in 73 patients with muscular dystrophy. Arch, intern. Med. 112, 199 (1963).Google Scholar
  297. Wharton, B. A.: An unusual variety of muscular dystrophy. Lancet 1965I, 248.Google Scholar
  298. Whorton, C. M., P. C. Hudgins, and J. J. Conners: Abnormal spectrophotometry absorption spectrums of myoglobin in two forms of progressive muscular dystrophy. New Engl. J. Med. 265, 1242 (1961).Google Scholar
  299. Whorton, C. M., P. C. Hudgins, J. J. Conners, and A. S. Nadas: The myoglobin molecule and its possible structural alterations in diseased states of skeletal and cardiac muscle. Sth. med. J. (Bgham, Ala.) 56, 583 (1963).CrossRefGoogle Scholar
  300. Wieme, R. J., and J. E. Herpol: Origin of lactate dehydrogenase isozyme pattern in the serum of patients having primary muscular dystrophy. Nature (Lond.) 194, 287 (1962).CrossRefGoogle Scholar
  301. Wiesmann, U., H. Moser, R. Richterich u. E. Rossi: Progressive Muskeldystrophie. VII. Die Erfassung von Heterozygoten der Duchenne Muskeldystrophie durch Messung der Serum-Kreatin-Kinase unter lokalisierter Arbeitsbelastung in Anoxie. Klin. Wschr. 43, 1015 (1965).PubMedCrossRefGoogle Scholar
  302. Willison, R. G.: Quantitative electromyography: the detection of carriers of Duchenne dystrophy. Excerpta Medica Foundation. International Congress Series 154, 14–15 (1967).Google Scholar
  303. Wilson, K. M., K. A. Evans, C. O. Carter: Creatine kinase levels in women who carry genes for three types of muscular dystrophy. Brit. med. J. 1965I, 750.Google Scholar
  304. Wohlfahrt, G.: Aktuelle Probleme der Muskelpathologie. Dtsch. Z. Nervenheilk. 173, 426 (1955).CrossRefGoogle Scholar
  305. Worden, D. K., and P. J. Vignos, jr.: Intellectual function in childhood progressive muscular dystrophy. Pediatrics 29, 968 (1962).PubMedGoogle Scholar
  306. Zellweger, H., and J. W. Hanson: Slowly progressive x-linked recessive muscular dystrophy (Type IIIb). Arch, intern. Med. 120, 525 (1967).Google Scholar
  307. Zintz, R.: Dystrophische Veränderungen in äußeren Augenmuskeln und Schultermuskeln bei der sog. progressiven Graefeschen Ophthalmoplegie. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  308. Zundel, W. S., and F. H. Tyler: The muscular dystrophies. New Engl. J. Med. 273, 537 (1965).Google Scholar

Kongenitale Muskeldystrophie

  1. Afifi, A. K., J. W. Smith, and H. Zellweger: Congenital non progressive myopathy. Neurology (Minneap.) 15, 371 (1965).Google Scholar
  2. D’Agostino, A. N., F. A. Ziter, M. L. Rallison, and P. F. Bray: Familial myopathy with abnormal muscle mitochondria. Arch. Neurol. 18, 388 (1968).PubMedCrossRefGoogle Scholar
  3. Banker, B. R.: In Discussion of Sher Rinalowski, Athanassiades und Aronson. Familial myotubular myopathy: A clinical pathological, histochemical and ultrastructural study. J. Neuropath, exp. Neurol. 26, 133 (1967).CrossRefGoogle Scholar
  4. Banker, B. R., M. Victor, and R. D. Adams: Arthrogryposis multiplex due to congenital muscular dystrophy. Brain 80, 319 (1957).PubMedCrossRefGoogle Scholar
  5. Bassöe, H. H.: Familial congenital muscular dystrophy with gonadal dysgenesia. J. clin. Endocrin. 16, 1614 (1956).CrossRefGoogle Scholar
  6. Basu, S. N., S. K. Banerjee, and A. M. Mukherjee: Amyotonia congenita syndrom; report of a family with affection of three siblings. J. Indian Pediat. Soc. 1, 353 (1962).Google Scholar
  7. Batten, F. E.: Three cases of myopathy. Infantile type. Brain 26, 147 (1903).Google Scholar
  8. Beetz, R.: Beitrag zur Lehre von den angeborenen Bewegungsdefekten im Bereich der Augen-,Gesichts- und Schultermuskulatur. J. Psychol. Neurol. (Lpz.) 20, 137 (1913).Google Scholar
  9. Bethlem, J., and F. E. Posthumus Meyjes: Congenital non-progressive central core disease of Shy and Magee. Psychiat. Neurol. Neurochir. 63, 246 (1960).Google Scholar
  10. Bethlem, J., J. van Gool, W. C. Hülsmann, and A. E. F. H. Meijer: Familial non-progressive myopathy with muscle cramps after exercise. A new disease associated with cores in the muscle fibres. Brain 89, 569 (1966).Google Scholar
  11. Black, H. H., and L. H. Landay: Marian’s syndrome, a familial disorder. Amer. J. Dis. Child. 89, 414 (1955).Google Scholar
  12. Bogaert, L. van, J. S. Bessa et A nunes Vicente: Sur une affection musculaire congénitale à évolution lentement favorable caractérisée par une cirrhose musculaire à dépôts proteiniques (reticulose musculaire ?). Acta neurol. belg. 10, 973 (1962).Google Scholar
  13. Capotorti, L.: Sindrome di Marfan e distrofia muscolare congenita. Acta paediat. lat. (Reggio Emilia) 19, 442 (1966).Google Scholar
  14. Chou, Shi-Ming: “Megaconial” mitochondria observed in a case of chronic polymyositis. Neurology (Minneap.) 17, 309 (1967).Google Scholar
  15. Coleman, R. F., T. L. Munsat, L. R. Thompson, and C. M. Pearson: Histochemical investigation of myotubular myopathy. Lab. Invest. 16, 647 (1967).Google Scholar
  16. Coleman, R. F., A. W. Nienhuis, W. J. Brown, T. L. Munsat, and C. M. Pearson: New myopathy with mitochondrial enzyme hyperactivity. J. Amer. med. Ass. 199, 624 (1967).CrossRefGoogle Scholar
  17. Conen, P. E., E. G. Murphy, and W. L. Donohue: Light and electron microscopic studies of “myogranules” in a child with hypotonia and muscle weakness. Canad. med. Ass. J. 89, 983 (1963).Google Scholar
  18. Drachman, D. B., and B. R. Banker: Arthrogryposis multiplex congenita. Arch. Neurol. 5, 77 (1961).PubMedCrossRefGoogle Scholar
  19. Dubansky, B., u. E. Svoboda: Angeborene beiderseitige Gesichtsmuskellähmung myo- pathischen Ursprungs. Confin. neurol. (Basel) 17, 130 (1957).CrossRefGoogle Scholar
  20. Dubowitz, V., and A. G. E. PEARSE: Oxidative enzymes and phosphorylase in central cor disease of muscle. Lancet 1960II, 23.Google Scholar
  21. Dubowitz, V., and M. Platts: Central core disease of muscle with focal wasting. J. Neurol. Neurosurg. Psychiat. 28, 432 (1965).PubMedCrossRefGoogle Scholar
  22. Engel, W. K.: The multiplicity of pathologic reactions of human skeletal muscle. In: Proceedings, Y. Intern. Congress of Neuropathology, Zürich. International Congress Series No. 100, Excerpta Medica Foundation, Amsterdam (1966 a).Google Scholar
  23. Engel, W. K., In discussion Sher, J. H., A. B. Rinalovski, T. J. Athanasiades, and S. M. Aronson: Familial myotubular myopathy: A clinical, pathological and ultrastructural study. J. Neuropath, exp. Neurol. 26, 133 (1967 a).Google Scholar
  24. Engel, W. K., A critique of congenital myopathies and other disorders. In: Exploratory concepts in muscular dystrophy and related disorders. Ed. A. T. Milhorat. Excerpta Medica Foundation Amsterdam. New York. London (1967b).Google Scholar
  25. Engel, W. K., and L. A. H. Hogenhuis: Genetically determined myopathies. In: Current concepts of myopathies. Ed. W. K. Engel. Philadelphia and Montreal: J. B. Lippincott Comp. 1965.Google Scholar
  26. Engel, W. K., and J. S. Resnick: Late-onset rod myopathy — a newly recognized, acquired and progressive disease. Neurology (Minneap.) 16, 308 (1966b).Google Scholar
  27. Engel, W. K., J. B. Foster, B. D. Hughes, H. E. Huxley, and R. Mahler: Central cor disease — an investigation of a rare muscle cell abnormality. Brain 84, 167 (1961).PubMedCrossRefGoogle Scholar
  28. Engel, W. K., T. Wanko, and G. M. Fenichel: Nemaline myopathy, a second case. Arch. Neurol. 11, 22 (1964).PubMedCrossRefGoogle Scholar
  29. Engel, A. G.: Recent studies on neuromuscular disease. Late-onset rod myopathy (a new syndrome ?): Light and electron microscopic observations in two cases. Proc. Mayo Clin. 41, 713 (1966).PubMedGoogle Scholar
  30. Engel, A. G., and M. R. Gomez: Nemaline (Z Disk) myopathy: Observations on the origin, structure and solubility properties of the nemaline structures. Neuropath, exp. Neurol. 26, 601 (1967).Google Scholar
  31. Farber, S., and J. M. Craig: Clinical pathological conference. The Children’s Medical Center, Boston (Mass.) J. Pediat. 53, 744 (1958).CrossRefGoogle Scholar
  32. Ford, F. R.: Diseases of the nervous system in infancy, childhood and adolescence. Springfield: Ch. C. Thomas 1960.Google Scholar
  33. Fukuyama, Y., M. Kawazura, and H. Haruna: A peculiar form of congenital progressive muscular dystrophy. Paediat. jap. 4, 5 (1960).Google Scholar
  34. Gamstorp, I.: Muskelhypotoni hos spädbarn. Läkartidningen (Stockh.) 64, 3299 (1967).Google Scholar
  35. Gibson, A.: Muscular infantilism. Arch, intern. Med. 27, 338 (1921).CrossRefGoogle Scholar
  36. Gonatas, N. K., G. M. Shy, and E. H. Godfrey: Nemaline myopathy. The origin of nemaline structures. New Engl. J. Med. 274, 535 (1966).Google Scholar
  37. Gordon, N.: Benign congenital hypotonia. A syndrome or a disease. Develop, med. Child. Neurol. 8, 330 (1966).Google Scholar
  38. Greenfield, J. B., T. Cornman, and G. M. Shy: The prognosticvalue of the muscle biopsie in the “Floppy Infant”. Brain 81, 461 (1958).PubMedCrossRefGoogle Scholar
  39. Gruner, J. E.: Sur quelques anomalie mitochondriales observées au cours d’affections musculaires variées. Soc. Biol. (Paris) 157, 181 (1963).Google Scholar
  40. Haushalter, P.: Sur la myatonie congénital (Maladie d’Oppenheim). Arch. Méd. Enf. 23, 133 (1920).Google Scholar
  41. Hopkins, I. J., J. It. Lindsey, and F. R. Ford: Nemaline myopathy. A long-term clinic-pathologic study of affected mother and daughter. Brain 89, 2 (1966).CrossRefGoogle Scholar
  42. Hudgson, P., D. Gardner-Medwin, J. J. Fulthorpe, and J. N. Walton: Nemaline myopathy. Neurology (Minneap.) 17, 1125 (1967).Google Scholar
  43. Joseph, R., D. Pellerin et J. C. Job: L’arthrogrypose multiple congénitale. Sem. Hôp. Paris 34, 525 (1958).Google Scholar
  44. Kinoshita, M., and T. E. Cadman: Myotubular myopathy. Arch. Neurol. 18, 265 (1968).PubMedCrossRefGoogle Scholar
  45. Kolin, I. S.: Nemaline myopathy. Amer. J. Dis. Child. 114, 95 (1967).PubMedGoogle Scholar
  46. Krabbe, K. H.: Kongenitale generaliseret muskelaplasi. Nord. Med. 35, 1756 (1947).Google Scholar
  47. Krabbe, K., Kongenitale generalisierte Muskelatrophien. Acta psyehiat. (Kbh.) 33, 94 (1958).CrossRefGoogle Scholar
  48. Lamy, M., M. L. Jammet et N. Aijan: Arthrogrypose ou syndrome arthrogrypoique ? A propos de dix observations. Sem. Hôp. Paris 41, 2419 (1965).Google Scholar
  49. de Lange, C.: Studien über angeborene Lähmungen, bzw. angeborene Hypotonie. II. Über die angeborene oder frühinfantile Form der Dystrophia musculorum progressiva (Erb). Acta paediat. (Kbh.) 20, 33 Suppl. 3, (1937).Google Scholar
  50. Lapresle, J.: Sur un type particulier de disposition myofibrillaire observé au microscope électronique dans un cas d’amyotrophie Charcot-Marie-Tooth. C. R. Soc. Biol. (Paris) 159, 568 (1965).Google Scholar
  51. Lelong, M., P. Canlorbe, Le Tan-Vinh, J. C. Dalloz, J. L. Corbin et J. Vassal: Myopathie chez une fille de 9 ans revelée à la naissance par une hypotonie musculaire generalisée. Arch, franc. Pédiat. 19, 581 (1962).Google Scholar
  52. Levesque, J., F. Lepage, U. Boeswillwald et J. Gruner: Deux cas de dystrophie musculaire familiale congénitale simulant une maladie de Wernig-Hoffmann-Oppenheim. Arch, franç. Pédiat. 13, 202 (1956).Google Scholar
  53. Lewis, A. J., and D. F. Besant: Muscular dystrophy in infancy. J. Pediat. 60, 376 (1962).PubMedCrossRefGoogle Scholar
  54. Lidge, R. T.: Hypotonia. J. Pediat. 45, 474 (1954).CrossRefGoogle Scholar
  55. Lindsley, J. R., I. J. Hopkins, and D. B. Clark: Pathology of nemaline myopathy. Studies of two adult cases including an autopsy. Bull. Johns Hopk. Hosp. 119, 6 (1966).Google Scholar
  56. Lipton, E. L., and S. H. Morgenstein: Arthrogryposis multiplex congenita in identical twins. Amer. J. Dis. Child. 89, 233 (1955).Google Scholar
  57. Luft, R., D. Ikkos, G. Palmieri, L. Ernster, and B. Afzelius: A case severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical and morphological study. J. clin. Invest. 41, 1776 (1962).PubMedCrossRefGoogle Scholar
  58. Norris, F. H., and P. J. Pannen: Hypothyroid myopathy. Arch. Neurol. 14, 574 (1966).PubMedCrossRefGoogle Scholar
  59. Pearson, C. M., and W. G. Fowler, JR.: Hereditary non-progressive muscular dystrophy inducing arthrogryposis syndrome. Brain 86, 75 (1963).PubMedCrossRefGoogle Scholar
  60. Prader, A., A. Labhart U. H. Willi: Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter. Schweiz, med. Wschr. 86, 1260 (1956).Google Scholar
  61. Price, H. M., D. C. Pease, and C. M. Pearson: Selectiv actin filement and Z-band degeneration induced by plasmocid. An electron microscopic study. Lab. Invest. 11, 549 (1962).PubMedGoogle Scholar
  62. Price, H. M., G. B. Gordon, C. M. Pearson, T. L. Munsat, and J. M. Blumberg: New evidence for excessive accumulation of Z-band material in nemaline myopathy. Proc. nat. Acad. Sci. (Wash.) 54, 1398 (1965).CrossRefGoogle Scholar
  63. Schreier, K., U. R. Huperz: Über die Hypoplasia musculorum generalisata congenita. Ann. paediat. (Basel) 186, 241 (1956).Google Scholar
  64. Shafig, S. A., V. Dubowitz, H. Peterson, and A. T. Milhorat: Nemaline myopathy. Report of a fatal case with histochemical and electronmicroscopic studies. Brain 90, 817 (1967).CrossRefGoogle Scholar
  65. Sher, J. H., A. B. Rimalovski, T. J. Athanassiades, and S. M. Aronson: Familial myotubular myopathy: A clinical pathological and ultrastructural study (abstract). J. Neuropath. exp. Neurol. 24, 132 (1967).Google Scholar
  66. Sher, J. H., A. B. Rimalovski, T. J. Athanassiades, and S. M. Aronson, Familial centronuclear myopathy. Neurology (Minneap.) 17, 727 (1967).Google Scholar
  67. Short, J. J. K.: Congenital muscular dystrophy. A case report with autopsy findings. Neurology (Minneap.) 13, 526 (1963).Google Scholar
  68. Shy, G. M., and K. R. Magee: A new congenital non progressive myopathy. Brain 79, 610 (1956).PubMedCrossRefGoogle Scholar
  69. Shy, G. M., W. K. Engel, J. E. Somers, and T. Wanko: Nemaline myopathy — a new congenital myopathy. Brain 86, 793 (1963).PubMedCrossRefGoogle Scholar
  70. Shy, G. M., Chemical abnormalities associated with muscle disease. Arch. phys. Med. 47, 126 (1966 a).Google Scholar
  71. Shy, G. M., N. K. Gonatas, and M. Perez: Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy. Brain 89, 133 (1966b).PubMedCrossRefGoogle Scholar
  72. Shy, G. M.: The chemical anatomy of muscle disease. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Ed. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966c.Google Scholar
  73. Sobel, J.: Essential or primary hypotonia in young children. Med. J. Rec. 124, 225 (1926).Google Scholar
  74. Spiro, A. J., and C. Kennedy: Hereditary occurrence of nemaline myopathy. Arch. Neurol. 13, 155 (1965).PubMedCrossRefGoogle Scholar
  75. Spiro, A. J., G. M. Shy, and N. K. Gonatas: Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch. Neurol. 14, 1 (1966).PubMedCrossRefGoogle Scholar
  76. Stern, W. G.: Arthrogryposis multiplex congenita. J. Amer. med. Ass. 81, 1507 (1923).CrossRefGoogle Scholar
  77. Turner, J. W. A.: Congenital myopathy simulating Oppenheims disease. III. Int. Congr. Neur. Copenhagen 1939.Google Scholar
  78. Turner, J. W. A., and F. Lees: Congenital myopathy — A fifty year follow up. Brain 85, 733 (1962).PubMedCrossRefGoogle Scholar
  79. Vassella, F., M. Mumenthaler, E. Rossi, H. Moser U. U. Wiesmann: Die kongenitale Muskeldystrophie. Dtsch. Z. Nervenheilk. 190, 349 (1967).CrossRefGoogle Scholar
  80. Walton, J. N.: The limp child. J. Neurol. Neurosurg. Psychiat. 20, 144 (1957).PubMedCrossRefGoogle Scholar
  81. Walton, J. N., L’enfant hypotonique. Acta paediat. belg. 12, 141 (1958).PubMedGoogle Scholar
  82. Walton, J. N., Muscular dystrophy and its relation to the other myopathies. Neuromuscular disorders 38, 378 (1961).Google Scholar
  83. Walton, J. N., N. Geschwind, and J. A. Simpson: Benign congenital myopathy with myasthenic features. J. Neurol. Neurosurg. Psychiat. 19, 224 (1956).PubMedCrossRefGoogle Scholar
  84. Wharton, B. A.: An unusual variety of muscular dystrophy. Lancet 1965I, 248.Google Scholar
  85. Wisselingh, C. J. von: Ein Fall von kongenitaler generalisierter Muskelhypoplasie. Maandschr. Kindergeneesk. 24, 234 (1956).Google Scholar
  86. Zellweger, H. H., J. W. Smith, and W. Cusminsky: Muscular hypotonia in infancy; diagnosis and differentiation. Rev. canad. Biol. 21, 600 (1962).Google Scholar
  87. Zellweger, H.: Congenital myopathies and their differentialdiagnosis. Päd. Fortbildungskurse 18, 105 (1966).Google Scholar

Myotonische Erkrankungen

  1. Aberfield, D. C., L. P. Hinterbuchner, and M. Schneider: Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome). Brain 88, 313 (1965).CrossRefGoogle Scholar
  2. Adams, R. D., U. J. J. Rebeiz: Histopathologic der mvotonischen Erkrankungen. In: Progressive Muskeldvstrophie-Mvotonie-Mvasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg New York: Springer 1966.Google Scholar
  3. Adie. W. J., and J. G. Greenfield: Dvstrophia mvotonica (Myotonia atrophica). Brain 46, 73 (1923).CrossRefGoogle Scholar
  4. Aleu, F. P., and A. K. Arm: Ultrastructure of muscle in myotonic dystrophy. Preliminary observations. Amer. J. Path. 45, 221 (1964).PubMedGoogle Scholar
  5. Allsop, J. L., K. Goulston, C. Johnston, D. Kelly, and L. Rail: Familial hyperkalaemic periodic paralysis. Austr. Ann. Med. 17, 55 (1964).Google Scholar
  6. Amici, R., e S. Negri: Sindrome miopatico-miotonica familiare atipica (Studio clinico ed elettromiografico). Sist. nerv. 3, 231 (1958).Google Scholar
  7. Amyot, R.: Un cas de syndrome de Sheehan avec myotome. Un. med. Can. 95, 944 (1966).Google Scholar
  8. Arnason, G., Th. Berge, and L. Dahlberg: Myocardial changes in dystrophia myotonica. Acta med. scand. 176, 535 (1964).CrossRefGoogle Scholar
  9. Ashworth, L. A. E., and C. Green: Plasma membranes: Phospholipid and sterol content. Science 151, 210 (1966).PubMedCrossRefGoogle Scholar
  10. Bartley, O., and G. Örndahl: The isometric relaxation phase of the left ventricle in myotonia. Acta radiol. (Stockh.) 1, 33 (1963).Google Scholar
  11. Bashour, F., P. Winchell, and J. Reddington: Myotonia atrophica and cyanosis. New Engl. J. Med. 252, 768 (1955).Google Scholar
  12. Batten, F. E., and H. P. Gibb: Myotonia atrophica. Brain 32, 187 (1909).CrossRefGoogle Scholar
  13. Baxter, D. W., and P. J. Dyck: Paramyotonia congenita. Canad. med. Ass. J. 85, 113 (1961).PubMedGoogle Scholar
  14. Beaser, S. B.: Clinical states with decreased glucose tolerance. J. Amer. med. Ass. 199, 990 (1967).CrossRefGoogle Scholar
  15. Beatty, C. H., G. M. Basinger, and R. M. Bocek: Pentose cycle activity in muscle from fetal, neonatal and infant rhesus monkeys. Arch. Biochem. 117, 275 (1966).PubMedCrossRefGoogle Scholar
  16. Becker, P. E.: Zur Frage der Heterogenic der erblichen Myotonien. Nervenarzt 28, 455 (1957).PubMedGoogle Scholar
  17. Becker, P. E., Die Heterogenic der Myotonien. Proceedings of the Sec. Internat. Congress of Human Genetics, Rome, Sept. 6–12, 1961.Google Scholar
  18. Becker, P. E., Zur Genetik der Myotonien (eine vorläufige Übersicht). Der Internist 4, 384 (1963).PubMedGoogle Scholar
  19. Becker, P. E., Myopathien. In: Handbuch der Humangenetik, Bd. 3, S. 1. Hrsg. P. E. Becker. Stuttgart: Thieme 1964.Google Scholar
  20. Becker, P. E., Zur Genetik der Myotonien. In: . Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  21. Bell, J.: The treasury of human inheritance, Vol. IV. Nervous diseases and muscular dystrophies. Part V, dystrophia myotonica and allied diseases. London: Cambridge University Press 1947.Google Scholar
  22. Benda, C. E., and E. M. Bixby: Urinary excretion of 17-ketosteroids in various conditions of oligophrenia correlated with some autopsy observations. J. clin. Endocr. 7, 503 (1947).PubMedCrossRefGoogle Scholar
  23. Benaim, S., and C. Worster-Drought: Dystrophia myotonica (with myotonia of the diaphragm causing pulmonarv hypoventilation with anoxemia and secondary polycythaemia). Med. ill. (Lond.) 8, 221 (1954).Google Scholar
  24. Berthold, H.: Zur pathologischen Anatomie der Dystrophia myotonica (Curschmann-Steinert). Dtsch. Z. Nervenheilk. 178, 394 (1958).CrossRefGoogle Scholar
  25. Bickerstaff, E. R.: Periodic paralysis. J. Neurol. Neurosurg. Psychiat. 16, 178 (1953).PubMedCrossRefGoogle Scholar
  26. Billings, E. G., and A. Ravin: A psychiatric study of patients manifesting dystrophia myotonica. Amer. J. Psychiat. 97, 2 (1941).Google Scholar
  27. Biörck, G., and P. Stigell: Dystrophia myotonica. A follow-up study of a family with associated heart disease. Acta med. scand. 175, 395 (1964).CrossRefGoogle Scholar
  28. Böhme, D. H., u. H. Hippius: Dystrophia myotonica Curschmann-Steinert mit Lues latens. (Kasuistischer Beitrag zur Klinik und Pathologischen Anatomie). Psychiat. et Neurol. (Basel) 148, 290 (1964).CrossRefGoogle Scholar
  29. Brand, E.: Intraoculäre Hypotonie bei Myotonikern. Ophthalmologica (Basel) 129, 81 (1955).CrossRefGoogle Scholar
  30. Brand, E., Erwiderung zu E. Kuhn und H.-J. Piesbergen: Hypotension des Bulbus und Katarakt bei myotonischer Dystrophie. Monatsbl. Augenheilk. 136, 241 (1960).Google Scholar
  31. Bredemann, W.: Kasuistik. Über paroxysmale Lähmung bei dystrophischer Myotonie. Ärztl. Wschr. 7, 202 (1952).Google Scholar
  32. Calderon, R.: Myotonic dystrophy: a neglected cause of mental retardation. J. Pediat. 68, 423 (1966).PubMedCrossRefGoogle Scholar
  33. Caldwell, P. C., and T. A. J. Prankerd: Phosphate esters in myotonic human muscle. J. Neurol. Neurosurg. Psychiat. 17, 127 (1954).PubMedCrossRefGoogle Scholar
  34. Campbell, J., and K. S. Rastogi: Evidence of maintained increase in insulin secretion induced by growth hormone, with further augmentation after meals or infusion of glucose, in dogs with portal vein cannuals. Diabetes 14, 444 (1965).Google Scholar
  35. Carson, M. J., and C. M. Pearson: Familial hyperkalemic periodic paralysis with myotonic features. J. Pediat, 64, 853 (1964).PubMedCrossRefGoogle Scholar
  36. Caughey, J. E., and J. Brown: Dystrophia myotonica: An endocrine study. Quart. J. Med. N. S. 11, No. 76, 303 (1950).Google Scholar
  37. Caughey, J. E., and W. G. Gray: Unilateral elevation of the diaphragm in dystrophia myotonica. Thorax 9, 67 (1954).PubMedCrossRefGoogle Scholar
  38. Caughey, J. E., and N. C. Myrianthopoulos: Dystrophia myotonica and related disorders. Springfield, I11.: Charles C. Thomas 1963.Google Scholar
  39. Caughey, J. E., and N. Pachomov: The diaphragm in dystrophia myotonica. J. Neurol. Neurosurg. Psychiat. 22, 311 (1959).PubMedCrossRefGoogle Scholar
  40. Caughey, J. E., Transitional forms between Myotonia congenita, Dystrophia myotonica and Paramyotonia congenita. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  41. Church, C.: The heart in myotonia dystrophica. Arch, intern. Med. 119, 176 (1967).Google Scholar
  42. Covernton, J. S., and M. H. Draper: A study of myotonia, with special reference to paramyotonia. Med. J. Austr. 2, 161 (1947).Google Scholar
  43. Curschmann, H.: Über familiäre atrophische Myotome. Dtsch. Z. Nervenheilk. 45, 161 (1912).CrossRefGoogle Scholar
  44. Curschmann, H., Beobachtungen und Untersuchungen bei atrophischer Myotonie. Dtsch. Z. Nervenheilk. 53, 114 (1915).CrossRefGoogle Scholar
  45. Curschmann, H., Zur Nosologie und Symptomatologie der myotonischen Dystrophie. Dtsch. Arch. klin. Med. 149, 129 (1925).Google Scholar
  46. Dana, C. L.: An atypical case of Thomsen’s disease (Myotonia congenita). Med. Ree. 33, 433 (1888).Google Scholar
  47. Decourt, J.: Les troubles endocriniens de la dystrophie myotonique (Maladie de Steinert). In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg- New York: Springer 1966.Google Scholar
  48. Delprat, C. C.: Over Thomsen’sche Ziekte (myotonia congenita en verwante toestanden). Ned. T. Geneesk. 2, 585 (1891).Google Scholar
  49. Delprat, C. C., II. Thomsen’sche Krankheit in einer paramyotonischen Familie. Dtsch. med. Wschr. 18, 158 (1892).CrossRefGoogle Scholar
  50. Dodge, Ph. R., I. Gamstorp, R. K. Byers, and P. Russell: Myotonic dystrophy in infancy and childhood. Pediatrics 35, 3 (1965).PubMedGoogle Scholar
  51. Drager, G. A., J. F. Hammill, and G. M. Shy: Paramyotonia congenita. Arch. Neurol. Psychiat. 80, 1 (1958).Google Scholar
  52. Drucker, W. D., L. P. Rowland, K. Sterling, and N. P. Christy: On the function of the endocrine glands in myotonic muscular dystrophy. Amer. J. Med. 31, 941 (1961).PubMedCrossRefGoogle Scholar
  53. Drucker, W. D., W. A. Blanc, and L. P. Rowland: The testes in myotonic muscular dystrophy: A clinical and pathologic study with a comparison with KHnefelter’s syndrome. J. clin. Endoer. 28, 59 (1963).CrossRefGoogle Scholar
  54. Dyken, P. R.: Extraocular myotonia in families with dystrophia myotonica. Neurology (Minneap.) 16, 738 (1966).Google Scholar
  55. Eberle, P., u. P. E. Becker: Chromosomenuntersuchungen bei Myotome. Humangenetik 1, 92 (1964).PubMedCrossRefGoogle Scholar
  56. Engel, A. G.: Persönliche Mitteilung 1967.Google Scholar
  57. Engel, A. G., E. H. Lambert, J. W. Rosevear, and W. N. Tauxe: Clinical and electromyographic studies in a patient with primary hypokalemic periodic paralyses Amer. J. Med. 38, 626 (1965).CrossRefGoogle Scholar
  58. Engel, W. K., and M. H. Brooke: Histochemistry of the myotonic disorders. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  59. Engel, W. K., D. E. Mcfarlin, G. A. Drews, and R. D. Wochner: Protein abnormalities in neuromuscular diseases. J. Amer. med. Ass. 195, 754 u. 837 (1966).Google Scholar
  60. Erb, W.: Die Thomsen’sche Krankheit (Myotonia congenita). Leipzig: F. C. W. Vogel 1886.Google Scholar
  61. Erbslöh, F.: Die myotonische Dystrophie. Eine intern-neurologische und bioptische Studie. Arch. Psychiat. Nervenkr. 201, 648 (1961).CrossRefGoogle Scholar
  62. Ess, H., u. K. H. Schiffer: Zur Bedeutung des Serum-Eiweißbildes in der Symptomatologie der myotonischen Dystrophien. Ärztl. Wschr. 14, 917 (1959).Google Scholar
  63. Eulenburg, A.: Über eine familiäre, durch 6 Generationen verfolgbare Form congenitaler Paramyotonie. Neurol. Centralbl. 5, 265 (1886).Google Scholar
  64. Evans, J. H., and R. W. Baker: Serum aldolase and the diagnosis of myopathy. Brain 80, 557 (1957).PubMedCrossRefGoogle Scholar
  65. Fardeau, M., J. Lapresle et M. Milhaud: C. R. Soc. Biol. (Paris) 159, 15 (1965).Google Scholar
  66. Fearrington, E. L., T. C. Gibson, and R. E. Churchill: Vectocardiographic and electrocardiographic findings in myotonia atrophica. A studv employing the Frank lead system. Amer. Heart J. 67, 599 (1964).PubMedCrossRefGoogle Scholar
  67. Felsch, G.. O. Hoffmeter u. G. Richter: Herzbeteiligung bei Dystrophia musculorum progressiva Erb. Z. ges. inn. Med. 21. 73 (1966).Google Scholar
  68. Findlay, L.: A case of Thomsen’s disease. Quart. J. Med. 5, 495 (1911/12).Google Scholar
  69. Fisch, Ch., and P. V. Evans: The heart in dystrophia mvotonica. Report of an autopsied case. New Engl. J. Med. 251, 527 (1954).Google Scholar
  70. Fisher, E. R., R. E. Cohn, and F. S. Danowski: Ultrastructural observations of skeletal muscle in myopathy and neuropathy with special reference to muscular dystrophy. Lab. Invest. 15, 778 (1966).PubMedGoogle Scholar
  71. French, E. B., and R. Kilpatrick: A Variety of Paramyotonia congenita. J. Neurol. Neurosurg. Psychiat. 20, 40 (1957).PubMedCrossRefGoogle Scholar
  72. Gamstorp, I., M. Hauge, H. F. Helweg-Larsen, H. Mjönes, and U. Sagild: Adynamia episodica hereditaria. Amer. J. Med. 23, 385 (1957).PubMedCrossRefGoogle Scholar
  73. Gamstorp, I., Adynamia episodica hereditaria and myotonia. Acta neurol. scand. 39, 41 (1963).PubMedCrossRefGoogle Scholar
  74. Garcin, R., M. Legrain, P. Rondot et M. Fardeau: Etude clinique et métabolique d’une observation de paramyotonie congénital d’Eulenburg. Documents ultrastructuraux concernant la biopsie musculaire. Rev. neurol. 115, 295 (1966).PubMedGoogle Scholar
  75. Gfeller, G., et J. L. Roux: L’atteinte cardiaque dans la myotome atrophique de Steinert. Cardiologia (Basel) 42, 200 (1963).Google Scholar
  76. Gibson, R.: Dystrophia myotonica in association with mental defect. Canad. med. Ass. J. 84, 1234 (1961).Google Scholar
  77. Gordin, R., M. Koskenoja, B.-A. Lamberg, C. Lindqvist, C. Olin-Lamberg, and T. Pikkanen: Myotonic dystrophy. Report of 5 cases. Acta med. scand. 166, 151 (1960).PubMedCrossRefGoogle Scholar
  78. Gottwald, W.: Psychopathologische Befunde bei Dystrophia myotonica (Curschmann-Steinert). Fortschr. Neurol. Psychiat. 24, 443 (1956).Google Scholar
  79. Gottwald, W., Symptomatische Psychosen, amnestischer Symptomenkomplex und Narkolepsie bei Dystrophia myotonica (Curschmann-Steinert). Nervenarzt 27, 112 (1956).PubMedGoogle Scholar
  80. Gottwald, W., Zwei weitere Fälle von Dystrophia myotonica (Curschmann-Steinert). Nervenarzt 33, 437 (1962).PubMedGoogle Scholar
  81. Greenfield, J. G.: Notes on a family of myotonia atrophica and early cataract, with a report of an additional case of “Myotonia atrophica”. Rev. Neurol. Psychiat. 9, 169 (1911).Google Scholar
  82. Griffith, T. W.: On myotonia. Quart. J. Med. 5, 229 (1911/12).Google Scholar
  83. Habeck, D.: Zur Frage des Kaliums bei der Myotonia congenita (Thomsen). Nervenarzt 32, 326 (1961).PubMedGoogle Scholar
  84. Hallen, O.: Über Schädelveränderungen bei der myotonischen Dystrophie. Dtsch. Z. Nervenheilk. 172, 467 (1955).Google Scholar
  85. Harvey, J. C., D. H. Sherbottrne, and C. I. Siegel: Smooth muscle involvement in myotonic dystrophy. Amer. J. Med. 39, 81 (1965).PubMedCrossRefGoogle Scholar
  86. Hoff, van’t W.: Familial myotonic periodic paralysis. Quart. J. Med. 31, 385 (1962).Google Scholar
  87. Hoffmann, J.: Ein Fall von Thomsen’scher Krankheit, compliciert durch Neuritis multiplex. Dtsch. Z. Nervenheilk. 9, 272 (1896).Google Scholar
  88. Hoffmann, J., Zur Lehre von der Thomsen’schen Krankheit mit besonderer Berücksichtigung des dabei vorkommenden Muskelschwundes. Dtsch. Z. Nervenheilk. 18, 198 (1900).CrossRefGoogle Scholar
  89. Holt, J. M., and E. H. N. Lambert: Case reports. Heart disease as the presenting feature in myotonia atrophica. Brit. Heart J. 26, 433 (1964).PubMedCrossRefGoogle Scholar
  90. Hudson, A. J.: Progressive neurological disorder and myotonia congenita associated with paramyotonia. Brain 86, 811 (1963).PubMedCrossRefGoogle Scholar
  91. Hudson, A. J., Paramyotonia Congenita. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  92. Hutchinson, E. C., and D. Longson: Testicular failure in dystrophia myotonica. Acta Endoer. 22, 264 (1956).Google Scholar
  93. Isherwood, J., and C. Mowdsley: Some radiological changes in dystrophia myotonica. Excerpta Medica Foundation, Int. Congress, Series No. 154, 20 (1967).Google Scholar
  94. Jackson, J. F.: Chromosomes in dystrophia myotonica. Lancet 1965I, 1225.Google Scholar
  95. Jackson, J. F., T. D. Dubose, J. M. Garrett, and B. I. Hirschowith: Esophageal and pulmonary studies in patients with myotonia dystrophica. Clin. Res. 14, 70 (1966).Google Scholar
  96. Jagenburg, O. R., and O. Sjaastad: The absorption of oral L-histidine in dystrophia myotonica. Acta neurol. scand. 42, 551 (1966).PubMedCrossRefGoogle Scholar
  97. de Jong, J. G. Y.: Dystrophia myotonica-Paramyotonia and Myotonia congenita. Assen: van Gor cum 1955.Google Scholar
  98. de Jong, J. G. Y., Dystrophia myotonica, paramyotonia and myotonia congenita. Acta genet. (Basel) 7, 310 (1957).Google Scholar
  99. de Jong, J. G. Y., Een familie mit een bijzondere vorm van myotome. Ned. T. Geneesk. 102, 890 (1958).Google Scholar
  100. de Jong, J. G. Y., Myotonia levior. IN: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg.: E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  101. Kilburn, K. H., J. T. Eagen, and A. Heyman: Cardiopulmonary insufficiency associated with myotonic dystrophy. Amer. J. Med. 26, 929 (1959).PubMedCrossRefGoogle Scholar
  102. Klein, D.: La dystrophic myotonique (Steinert) et la myotome congénitale (Thomsen) en Suisse. Etude clinique, génétique et démographique. J. Génét. hum. 7, Suppl. 1 (1958).Google Scholar
  103. Koch, G.: Paramyotonia congenita (ihre nosologische und erbpathologische Stellung innerhalb der erblichen Myotonien). Erbanb. 11, 167 (1943).Google Scholar
  104. Koch, E., M. Taubert u. H. J. Wachtel: Symptomatologie und Erbgang der myotonen Dystrophie. Medizinische 40, 1 (1956).Google Scholar
  105. Kohn, R., u. E. Kuhn: Kardiale Beteiligung bei Myopathien. Verh. dtsch. Ges. inn. Med. 71, 641 (1965).PubMedGoogle Scholar
  106. Krull, G. H., B. Leijnse, M. de Vlieger, W. P. J. Vietor, J. W. G. Ter Braak, and J. Gefbrandy: Myotoniad produced by an unknown humeral substance. Lancet 1966II, 668.Google Scholar
  107. Kuhn, E.: Aldolasebestimmungen im Serum bei myotonischer Dystrophie. Klin. Wschr. 37, 236 (1959).PubMedCrossRefGoogle Scholar
  108. Kuhn, E., Studien zur Pathogenese der myotonischen Dystrophie. Berlin-Heidelberg-New York: Springer 1961.Google Scholar
  109. Kuhn, E., Myotonia congenita und Dystrophia myotonica. In: Progressive Muskeldystrophie-Myotonie-Myasthenie. Hrsg. E. Kuhn. Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  110. Kuhn, E., Myotonia. In: Proceedings of the Second Congress of Neurogenetic, Neurophthalmology etc. Ed. A. Barbeau. Amsterdam-New York-London: Excerpta Medica Foundation (im Druck).Google Scholar
  111. Kuhn, E., u. W. Ey: Innenohrschwerhörigkeit bei Dystrophia myotonica und Dystrophia musculorum progressiva. Dtsch. med. Wschr. 91, 947 (1966).PubMedCrossRefGoogle Scholar
  112. Kuhn, E., u. A. Heller: Kontraktionsstörungen am Herzmuskel bei myotonischer Dystrophie. Schweiz, med. Wschr. 89, 1008 (1959).Google Scholar
  113. Kuhn, E., u. K. Holldack: Untersuchungen am Herzen bei myotonischer Dystrophie. Nervenarzt 26, 334 (1955).PubMedGoogle Scholar
  114. Kuhn, E., H. J. Piesbergen: Hypotension des Bulbus und Katarakt bei myotonischer Dystrophie. Klin. Mbl. Augenheilk. 130, 329 (1957).Google Scholar
  115. Kuhn, E., u. W. Stein: Modellmyotonie nach 2,4 Dichlorphenoxyacetat (2,4 D) bei der Ratte: In vitro- und in vivo-Untersuchungen über den Einfluß von 2,4 D auf den Energiestoffwechsel des Muskels. Klin. Wschr. 43, 673 (1965).PubMedCrossRefGoogle Scholar
  116. Kuhn, E., u. W. Stein: Modellmyotonie nach 2,4 Dichlorphenoxyacetat (2,4 D): Calciumaufnahme der Vesikel des sarkoplasmatischen Retikulums, unter 2,4 D. Klin. Wschr. 44, 700 (1966).CrossRefGoogle Scholar
  117. Kuhn, E., u. H. Weicker: Serumproteine und Lipide bei myotonischer Dystrophie. Schweiz, med. Wschr. 87, 460 (1957).Google Scholar
  118. Kuhn, E., u. W. Wörner: Die Serum-Transaminasen bei Patienten mit myotonischer Dystrophie. Z. klin. Med. 155, 544 (1959).PubMedGoogle Scholar
  119. Kuhn, E., J. Schaaf, W. Wenzu. W. Stein: Untersuchungen am Verdauungstrakt bei myotonischer Dystrophie. Schweiz, med. Wschr. 95, 1263 (1965).Google Scholar
  120. Kuhn, E., H. Schönthal U. J. Schaaf: Zwerchfell und Lungenfunktion bei myotonischer Dystrophie. Schweiz, med. Wschr. 96, 281 (1966).Google Scholar
  121. Kuhn, E., D. Seiler, K. H. Weber, R. Kern, U. Fuchs u. H. Pfisterer: Bedeutung von Aminen, Steroiden und Fettsäuren für das Auftreten von Myotonie im Tierexperiment. In Vorbereitung.Google Scholar
  122. Kuhn, E., H. G. Stehlen u. W. Stein: Kreatinphosphokinase (CPK) im Serum bei myotonischer Dystrophie. Klin. Wschr. 40, 744 (1962).PubMedCrossRefGoogle Scholar
  123. Kuhn, E., G. Burger, E. A. Taalouch, R. Kern, B. Neundörfer u. H. Pfisterer: Myotonie am Rattenzwerchfell nach 20,25-Diazacholesterin und ihre Besonderheiten. In Vorbereitung.Google Scholar
  124. Kuhn, E., W. Dorow, W. Kahlke u. H. Pfisterer: Myotonie nach 20,25-Diazacholesterin bei der Ratte — Elektromyographie, Mechanokardiographie, Fettsäurenanalyse der Phosphatide des Skelettmuskels. Klin. Wschr. 46, 1043 (1968).PubMedCrossRefGoogle Scholar
  125. Lajoie, W. J.: Paramyotonia congenita, clinical features and electromyographical findings. Arch. phys. Med. 42, 327 (1960).Google Scholar
  126. Leyburn, P., and J. N. Walton: The effect of changes in serum potassium upon myotonia. J. Neurol. Neurosurg. Psychiat. 23, 119 (1960).PubMedCrossRefGoogle Scholar
  127. Leyden, E.: Klinik der Rückenmarkskrankheiten. Bd. 1. Berlin: Hirschwald 1874.Google Scholar
  128. Litchfield, J. A.: Case reports. A-V dissociation in dystrophia myotonica. Brit. Heart J. 15, 357 (1953).PubMedCrossRefGoogle Scholar
  129. Liversedge, L. A., and M. J. D. Newman: The treatment of myotonia. Brain. 79, 395 (1956).PubMedCrossRefGoogle Scholar
  130. Löwenthal, A., et M. van Sande: Nouvelles déterminations des fractions proteiniques dans le serum de patients atteints d’affections musculaires. Acta neurol. belg. 11, 864 (1956).Google Scholar
  131. Maas, O., and A. S. Paterson: The identity of myotonia congenita (Thomsen’s disease), dystrophia myotonica (myotonia atrophica) and paramyotonia. Brain 62, 198 (1939).CrossRefGoogle Scholar
  132. Maas, O., and A. S. Paterson, Dystrophia myotonica as a generalised disease. Mschr. Psychiat. Neurol. 113, 79 (1947).CrossRefGoogle Scholar
  133. Maas, O., and A. S. Paterson, Mvotonia congenita dvstrophia mvotonica and paramvotonia: reaffirmation of their identity- Brain 73, 318 (1950).Google Scholar
  134. Magee. K. R.: A study of paramyotonia congenita. Arch. Neurol. 8, 461 (1963).CrossRefGoogle Scholar
  135. Magee. K. R., Paramyotonia congenita. Arch. Neurol. 14, 461 (1966).CrossRefGoogle Scholar
  136. Marshall, J.: Observations on a case of myotonia paradoxa. J. Neurol. Neurosurg. Psychiat. 15, 206 (1952).PubMedCrossRefGoogle Scholar
  137. Marshall, J., The nuclear sex-chromatin pattern in dystrophia myotonica. Lancet 1958, 1209.Google Scholar
  138. Mertens, H. G., u. H. Nowakoski: Die endokrinen Drüsen bei den Myotonien. Dtsch. Z. Nervenheilk. 172, 128 (1954).CrossRefGoogle Scholar
  139. Meulen, J. P. van der, G. J. Gilbert, and C. A. Kane: Familial hyperkalemic paralysis with myotonia. New Engl. J. Med. 264, 1 (1961).Google Scholar
  140. Milhaud, M., M. Fardeau et J. Lapresle: Contribution à l’étude lésions élémentaires des muscles scelettique ultrastructure des fibres annulaires (observer dans la dystrophie myotonique). C. R. Soc. Biol. (Paris) 158, 2274 (1964).Google Scholar
  141. Mjönes, H.: Die psychischen Veränderungen bei dystrophischer Myotonie. Acta psychiat. (Kbh.) 34, Suppl. 136 (1959).Google Scholar
  142. Nogues, E., et J. Sirol: Maladie de Thomsen à forme fruste avec atrophie musculaire. Nouv. Iconogr. Salpet. 12. 15 (1899).Google Scholar
  143. Örndahl, G.: Mechanical registration of the effects of acetylcholine and choline. Acta med. scand. 172, 1 (1962).Google Scholar
  144. Örndahl, G., Myotonic human musculature: Stimulation with depolarizing agents. Acta medica scand. 172, 1 (1962).Google Scholar
  145. Örndahl, G., O. Thulesius, S. Eneström, and O. Dehlin: The heart in myotonic disease. Acta med. scand. 176, 479 (1964).PubMedCrossRefGoogle Scholar
  146. Payne, Ch. A., and J. C. Greenfield, jr.: Electrocardiographic abnormalities associatedwith myotonic dystrophy. Amer. Heart J. 65, 436 (1963).PubMedCrossRefGoogle Scholar
  147. Pearson, C. M., N. C. Kar, J. B. Peter, T. L. Munsat, W. M. Fowler jr., and R. F. Coleman: Myotonic dystrophy: its variable genetic, histological and biochemical expressions. Excerpta Medica Foundation. Intern. Congr. Series No. 154, 19 (1967).Google Scholar
  148. Perkoff, G. T.: Studies of human myoglobin in several diseases of muscle. New Engl. J. Med. 270, 263 (1964).Google Scholar
  149. Petkovich, N. J., M. Dunn, and W. Reed: Myotonia dystrophica with A-V-dissociation and Stokes-Adams attacks. A case report and review of the literature. Amer. Heart J. 68, 391 (1964).PubMedCrossRefGoogle Scholar
  150. Phemister, J. C., and J. M. Small: Hypersomnia in dystrophia myotonica. J. Neurol. Neurosurg. Psychiat. 24, 173 (1961).PubMedCrossRefGoogle Scholar
  151. Pruzanski, W.: Variants of myotonic dystrophy in pre-adolescent life. (The syndrome of myotonic dysembryoplasia). Brain 89, 563 (1966).PubMedCrossRefGoogle Scholar
  152. Pruzanski, W., and A. G. Huvos: Smooth muscle involvement in primary muscle disease. I. Myotonic dystrophy. Arch. Neurol. (Chic.) 83, 229 (1967).Google Scholar
  153. Pruzanski, W., and A. Profis: Dysfunction of the alimentary tract in myotonic dystrophy. Israel J. med. Sci. 2, 59 (1966).Google Scholar
  154. Ravin, A.: Studies in dystrophia myotonica. III. Experimental studies in myotonia. Arch. Neurol. Psychiat. (Chic.) 43, 649 (1940).Google Scholar
  155. Ravin, A., and J. J. Waring: Studies in dystrophia myotonica. I. Hereditary aspects. Amer. J. med. Sci. 197, 593 (1939).Google Scholar
  156. Refsum, S., A. Lounum, O. Sjaastad, and A. Engeset: Dystrophia myotonica. Repeated pneumoencephalographic studies in ten patients. Neurology 17, 345 (1967).PubMedGoogle Scholar
  157. Rich, E. G.: An unique form of motor paralysis due to cold. Med. News (N. Y.) 65, 210 (1894).Google Scholar
  158. Riecker, G., H. Dobbelstein u. D. Röhl: Messungen des Membranpotentials einzelner quergestreifter Muskelzellen bei Myotonia congenita (Thomsen). Klin. Wschr. 42, 519 (1964).PubMedCrossRefGoogle Scholar
  159. Rosman, N. P., and J. J. Rebeiz: The cerebral defect and myopathy in myotonic dystrophv. Neurology 17, 1106 (1967).PubMedGoogle Scholar
  160. Samaha, F. J.: Von Eulenburg’s paramyotonia. A clinical study of restricted myotonia and episodic paralysis successfully controlled by chlorothiazide. Trans. Amer. neurol. Ass. 89, 87 (1964).PubMedGoogle Scholar
  161. Samaha, F. J., J. M. Schröder, J. Rebeiz, and R. D. Adams: Studies in myotonia. Biochemical and electron microscopic studies in myotonia congenita and myotonia dystrophica. Arch. Neurol. (Chic.) 17, 22 (1967).CrossRefGoogle Scholar
  162. Sautter, H.: Myotonie und Cataracta myotonica. Arch. Ophthal. 143, 1 (1941).CrossRefGoogle Scholar
  163. Schimrigk, K., D. Matzelt, u. H. G. Mertens: Vergleichende Untersuchungen der endokrinen Drüsen und der Enzymaktivitäten bei Dystrophia myotonica und Myotonia congenita. Klin. Wschr. 44, 76 (1966).Google Scholar
  164. Schotland, D. L., D. Spiro, and P. Carmel: Ultrastructural studies of ring fibres in human muscle disease. J. Neuropath, exp. Neurol. 25, 431 (1966).CrossRefGoogle Scholar
  165. Schönthal, H., W. Stein, E. Kuhn, H. Pfisterer u. R. Kruse: Verschwinden der Myotome bei einer Patientin mit myotonischer Dystrophie während AT 10-intoxikationsbedingter Elektrolytveränderungen. Schweiz, med. Wschr. 94, 1164 (1964).Google Scholar
  166. Schröder, J. M., and R. D. Adams: The ultrastructural morphology of the muscle fiber in myotonic dystrophy. Acta Neuropath. 10, 218 (1968).PubMedCrossRefGoogle Scholar
  167. Schuman, B. M., J. A. Rinaldo jr., and J. D. Darnley: Visceral changes in myotonic dystrophy. Ann. int. Med. 63, 793 (1965).PubMedGoogle Scholar
  168. Schuster, M. M., D. E. Tow, and D. H. Sherbourne: Anal sphincter abnormalities characteristic of myotonic dystrophy. Gastroenterology 49, 641 (1965).PubMedGoogle Scholar
  169. Seeligmüller, A.: Tonische Krämpfe in willkürlich beweglichen Muskeln (Muskelhypertrophie). Dtsch. med. Wschr. 2, 389 (1876).Google Scholar
  170. Seiler, D., u. E. Kuhn: Amine als Auslöser von Myotonie. In Vorbereitung.Google Scholar
  171. Serog, Breslau, M.: Paramyotonia congenita. Z. ges. Neurol. Psychiat. 129, 481 (1930).Google Scholar
  172. Siegel, Ch. I., Th. R. Hendrix, and J. C. Harvey: The swallowing disorder in myotonia dystrophica. Gastroenterology 50, 541 (1966).PubMedGoogle Scholar
  173. Sjaastad, O.: Histamine formation after oral L-histidine in health and dystrophia myotonica. Acta med. scand. 180, 581 (1966).PubMedCrossRefGoogle Scholar
  174. Sjaastad, O., On the metabolism of histamine in dystrophia myotonica. Acta neurol. scand. 43, 106 (1967).PubMedCrossRefGoogle Scholar
  175. Slatt, B.: Myotonia dystrophia: a review of 17 cases. Canad. med. Ass. J. 85, 250 (1961).Google Scholar
  176. Sölder, F. von: Zur Kenntnis der Paramyotonia congenita (Eulenburg). Wien. klin. Wschr. 8, 120 (1895).Google Scholar
  177. Stevens, J. R.: Familial periodic paralysis, myotonia, progressive amyotrophy and pes cavus in members of a single family. Arch. Neurol. Psychiat. 72, 726 (1954).Google Scholar
  178. Strümpell, A.: II. Tonische Krämpfe in willkürlich bewegten Muskeln (Myotonia congenita). Berl. klin. Wschr. 18, 119 (1881).Google Scholar
  179. Stanbury, J. B., R. R. Goldsmith, and M. Gillis: Myotonie dystrophy associated with thyroid disease. J. clin. Endocr. 14, 1437 (1954).PubMedCrossRefGoogle Scholar
  180. Steinert, H.: Myopathologische Beiträge. I. Über das klinische und anatomische Bild des Muskelschwunds der Myotoniker. Dtsch. Z. Nervenheilk. 37, 58 (1909).Google Scholar
  181. Steinert, H.: Ein neuer Fall von atrophischer Myotonie. Dtsch. Z. Nervenheilk. 39, 168 (1910).CrossRefGoogle Scholar
  182. Talma, S.: Over Myotonia acquisita. Weekbl. Neederland. Geneesk. 11, 321 (1892).Google Scholar
  183. Thomasen, E.: Myotonia: Thomsen’s disease. Paramyotonia, Dystrophia myotonica. Aarhus: Universitetsforlaget 1948.Google Scholar
  184. Thomsen, J.: Tonische Krämpfe in willkürlich beweglichen Muskeln in Folge von ererbter psychischer Disposition. Arch. Psychiat. Nervenkrankh. 6, 702 (1876).CrossRefGoogle Scholar
  185. Thomson, W. H. S., P. Leyburn, and J. N. Walton: Serum enzyme activity in muscular dystrophy. Brit. med. J. 1900 II, 1276.Google Scholar
  186. Thomson, W. H. S., The clinical biochemistry of the muscular dystrophies. Advan. clin. Chem. 7, 137 (1964).Google Scholar
  187. Tschumy, W. jr.: Paramyotonia. Arch. int. Med. 94, 443 (1954).Google Scholar
  188. Turpin, R., B. Caille, J. Lafourcade, M. Bébe, M. Malafosse, P. Nayrac, P. Warot, P. Fossati, G. Milbled et S. Meignie: Maladie familiale prenant chez certains sujets l’aspect d’une paramyotonie d’Eulenburg et rappelant chez d’autres l’adynamie épisodique héréditaire. Presse méd. 72, 3179 (1964).PubMedGoogle Scholar
  189. Vanier, T. M.: Dystrophia myotonica in childhood. Brit. med. J. 1960II, 1284.Google Scholar
  190. Vogt, A.: Die Katarakt bei myotonischer Dystrophie. Schweiz, med. Wschr. 1921 II, 669.Google Scholar
  191. Waring, J. J., A. Ravin, and CH. E. Walker jr.: Studies in dystrophia myotonica. II. Clinical features and treatment. Arch. int. Med. 65, 763 (1940).CrossRefGoogle Scholar
  192. Watters, G. V., and T. W. Williams: Early onset myotonic dystrophy. Arch. Neurol. (Chic.) 17, 137 (1967).CrossRefGoogle Scholar
  193. Wawersik, F.: Zur Kasuistik der Paramyotonie. Nervenarzt 18, 463 (1947).PubMedGoogle Scholar
  194. Wechsler, W., u. H. Hager: Elektronenmikroskopische Untersuchungen bei myotonischer Muskeldystrophie. Arch. Psychiat. Nervenkr. 201, 668 (1961).PubMedCrossRefGoogle Scholar
  195. Welsh, J. D., G. R. Haase, and T. E. Bynum: Myotonie muscular dystrophy. Systemic manifestations. Arch. int. Med. 114, 669 (1894).CrossRefGoogle Scholar
  196. Wochner, D., G. Drews, W. Strober, and T. A. Waldmann: Immunglobulin metabolism in myotonic dystrophy. Clin. Res. 13, 291 (1965).Google Scholar
  197. Wochner, D., G. Drews, W. Strober, and T. A. Waldmann, Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: A hereditary error of immunoglobulin metabolism. J. clin. Invest. 45, 321 (1966).PubMedCrossRefGoogle Scholar
  198. Wohlfahrt, G.: Dystrophia myotonica and myotonia congenita. Histopathologic studies with special reference to changes in the muscles. J. Neuropath. 10, 109 (1951).CrossRefGoogle Scholar
  199. Wolintz, A. H., E. H. Sonnenblick, and W. K. Engel: Stokes-Adams syndrome and atrial arrhythmias as the presenting symptoms of myotonic dystrophy, with response to electrocardioversion. Ann. intern. Med. 65, 1260 (1966).PubMedGoogle Scholar
  200. Wyss. F.: Dystrophia myotonica und Klinefelter-Syndrom. Helv. med. Acta 23. 578 (1956).PubMedGoogle Scholar
  201. Zinneman, H. H., and J. Rotstein: A study of gamma globulin in dvstrophia mvotonica. J. Lab. clin. Med. 47, 907 (1956).PubMedGoogle Scholar

Glykogenspeicherkrankheiten

  1. Bale, P., J. F. Hammett, and F. C. Neale: Histopathology of McArdle’s disease in a family. Path. Bact. 94, 293 (1967).CrossRefGoogle Scholar
  2. Baudhuin, P., H. G. Hers, and H. Loeb: Electron microscopic and biochemical study of type II glycogenosis. Lab. Invest. 13, 1139 (1964).PubMedGoogle Scholar
  3. Benoit, F. L., and R. H. Watten: Observations on venous pH alterations after ischemic exercise in myopathic disorders. Amer. J. med. Sci. 251, 532 (1966).PubMedCrossRefGoogle Scholar
  4. Bischoff, G.: Zum klinischen Bild der Glykogen-Speicherungskrankheit (Glykogenose). Z. Kinderheilk. 52, 722 (1932).CrossRefGoogle Scholar
  5. Cardiff, R. D.: A histochemical and electron microscopic study of skeletal muscle in a case of Pompe’s disease (Glykogenosis II). Pediatrics 37, 249 (1966).PubMedGoogle Scholar
  6. Cori, G. T., and C. F. Cori: The effect of stimulation and recovery on the phosphorylase a content of muscle. J. biol. Chem. 158, 333 (1945).Google Scholar
  7. Cori, G. T., and C. F. Cori, Glucose-6-phosphatose of the liver in glycogen storage disease. J. biol. Chem. 199, 661 (1952).PubMedGoogle Scholar
  8. Dyken, M. L., D. M. Smith, and R. L. Peake: An electromyographic diagnostic screening test in McArdle’s disease and a case report. Neurology 17, 45 (1967).PubMedGoogle Scholar
  9. Engel, W. K., E. L. Eyerman, and H. E. Williams: Late-onset type of skeletal muscle phosphorylase deficiency. — A new familial variety with completely and partially affected subjects. New Engl. J. Med. 268, 135 (1963).Google Scholar
  10. Forbes, G. B.: Glycogenstorage disease: report of a case with abnormal glycogenstructure in liver and skeletal muscle. J. Pediat. 42, 645 (1953).PubMedCrossRefGoogle Scholar
  11. van Gierke, E.: Hepato-nephromegalia glycogenica. Beitr. path. Anat. 82, 497 (1929).Google Scholar
  12. Günther, R.: Beitrag zur Kenntnis der Glykogenspeicherkrankheit. Virchow’s Arch. path. Anat. 304, 87 (1939).Google Scholar
  13. Hers, H. G.: Recent developments in the biochemistry of glycogen storage disease and of fructose intolerance. Chem. Weekbl. 57, 437 (1961).Google Scholar
  14. Hers, H. G. Alpha glucosidase deficiency in generalized glycogen storage disease (Pompe’s disease). Biochem. J. 86, 11 (1963).PubMedGoogle Scholar
  15. Hers, H. G., Glycogen storage disease, type II. In: Control of glycogen metabolism. A Ciba Foundation Symposium. Ed.: W. J. Whelan, and M. P. Cameron. London: Churchill 1964.Google Scholar
  16. Huijing, F., S. van Creveld, G. Losekoot: Diagnosis of generalized glycogen storage disease (Pompe’s disease). J. Pediat. 63, 984 (1963).PubMedCrossRefGoogle Scholar
  17. Illingworth, B., G. T. Cori, and C. F. Cori: Amylo-l,6-glucosidase in muscle tissue in generalised glycogen storage disease. J. biol. Chem. 218, 213 (1956).Google Scholar
  18. Illingworth, B., Glycogen storage disease. Amer. J. clin. Nutr. 9, 683 (1961).Google Scholar
  19. Illingworth, B., and D. H. Brown: Glycogen storage diseases, types III, IV and VI. IN: Control of glycogen metabolism. A Ciba Foundation Symposium. Ed. W. J. Whelan, and M. P. Cameron. London: Churchill 1964.Google Scholar
  20. Illingworth, B., and H. Zellweger: α-1,4-glucosidase activity in leucocytes from the family of two brothers who lack this enzyme in muscle. Biochem. J. 101, 16 C (1966).Google Scholar
  21. Kuhn, E.: Muskelphosphorvlasemangel (McArdle). Therapiewoche 18, 48, 2166 (1968).Google Scholar
  22. Larson, L. E., H. Linderholm, R. Muller, T. Ringqvist, and R. Sornas: Hereditary metabolic myopathy with paroxysmal myoglobinuria due to abnormal glycolysis. J. Neurol. Neurosurg. Psychiat. 27, 361 (1964).CrossRefGoogle Scholar
  23. Layzer, R. B., L. P. Rowland, and H. M. Ranney: Muscle phosphofructokinase deficiency. Arch. Neurol. (Chic.) 17, 512 (1967).CrossRefGoogle Scholar
  24. Lehoczky, T., M. Halasy, G. Simon, G. Harmos: Skeletal muscle glycogenosis in identical twins. Brit. med. J. 1964II, 802.Google Scholar
  25. Lehoczky, T., M. Halasy, G. Simon, G. Harmos, Glycogenic myopathy. J. Neurol. Sci. 2, 366 (1965).PubMedCrossRefGoogle Scholar
  26. Löhr, G. W.: Pathogenese und Differentialdiagnose der Glykogenosen. Dtsch. med. Wschr. 90, 1549 (1965).CrossRefGoogle Scholar
  27. McArdle, B.: Myopathy due to a defect in muscle glycogen brackdown. Clin. Sci. 10, 13 (1951).Google Scholar
  28. McDonald Holmes, J., C. R. Houghton, and A. L. Woolf: A myopathy presenting in adult life with features suggestive of glycogen storage disease. J. Neurol. Neurosurg. Psychiat. 23, 302 (1960).Google Scholar
  29. Mellick, R. S., R. F. Mahler, and B. P. Hughes: McArdle’s syndrome. Phosphorylasedeficient myopathy. Lancet 1962I, 1045.Google Scholar
  30. Meyer, K. H., et P. Bernfeld: Recherches sur l’amidon V. L’amylopectine. Helv. chim. Acta 23, 875 (1940).Google Scholar
  31. Meyer, K. H., et M. Fuld: Recherches sur l’amidon. XII. L’arrangement des restes de glucose dans le glygogene. Helv. chim. Acta 24, 375 (1941).Google Scholar
  32. Meyer, K. H., The chemistry of glycogen. Enzymol. 3, 109 (1943).Google Scholar
  33. Mommaerts, W. F. H. M., B. Illingworth, C. M. Pearson, R. J. Guillory, and K. Seraydarian: A functional disorder of muscle associated with the absence of phosphorylase. Proc. nat. Acad. Sci. (Wash.) 45, 791 (1959).Google Scholar
  34. Nitowsky, H. M., and A. Greenfield: Lysosomal α-glucosidase in type II glycogenosis; activity in leucocytes and cell cultures in relation to genotype. J. Lab. clin. Med. 69, 472 (1967).PubMedGoogle Scholar
  35. Nixon, J. C., W. K. Hobbs, and J. Greenblatt: Myoglobinuria and skeletal muscle phosphorylase deficiency: Report of a case of McArdle’s disease. Canad. med. Ass. J. 94, 977 (1966).Google Scholar
  36. Paluello, F. M., C. B. Bruni, and H. Spiele: Type III, a glycogenosis. A biochemical and ultrastructural study. Virchow’s Arch. path. Anat. 343, 164 (1967).CrossRefGoogle Scholar
  37. Pearson, C. M., D. G. Rimer, and W. F. H. M. Mommaerts: A metabolic myopathy due to absence of muscle phosphorylase. Amer. J. Med. 30, 502 (1961).Google Scholar
  38. Pernow, H. B.: Berydelsen av fettsyramobilisering vid myopati. Nord. Med. 75, 693 (1966).Google Scholar
  39. Pernow, H. B., R. J. Havel, and D. B. Jennings: The second wind phenomenon in McArdle’s syndrome. Acta med. scand. 182, Suppl. 472, 294 (1967).Google Scholar
  40. Perez-Trevino, C., B. Molina-Zapata, C. Guzman-Garcia, A. Merizalde, and A. Ricalde: Glycogen storage disease of the heart. Amer. J. Cardiol. 16, 137 (1965).CrossRefGoogle Scholar
  41. Pompe, J. C.: Over idiopatische hypertrophy van het hart. Ned. T. Geneesk. 76, 304 (1932).Google Scholar
  42. Porte, D. jr., D. W. Crawford, D. B. Jennings, C. Aber, and M. B. McIlroy: Cardiovascular and metabolic responses to exercise in a patient with McArdle’s syndrome. New Engl. J. Med. 275, 406 (1966).Google Scholar
  43. Putschar, W.: Über angeborene Glykogenspeicherkrankheit des Herzens — Thesaurismosis glycogenica [v. Gierke]. Beitr. path. Anat. 90, 222 (1932).Google Scholar
  44. Robbins, P. W.: Immunological study of human muscle lacking phosphorylase. Fed. Proc. 19, 193 (1960).Google Scholar
  45. Rowland, L. P., S. Fahn, and D. L. Schotland: McArdle’s disease: Hereditary myopathy due to absence of muscle phosphorylase. Arch. Neurol. 9, 325 (1963).PubMedCrossRefGoogle Scholar
  46. Rowland, L. P., R. E. Lovelace, D. L. Schotland, S. Araki, and P. Carmel: The clinical diagnosis of McArdle’s disease. Identification of another family with deficiency of muscle phosphorylase. Neurology 16, 93 (1966).PubMedGoogle Scholar
  47. Salter, R. H., D. G. Adamson, and G. W. Pearce: McArdle’s syndrome (Myophosphorylase deficiency). A study of a family. Quart. J. Med. 36, 565 (1967).PubMedGoogle Scholar
  48. Satoyoshi, E., and H. Kowa: A myopathy due to glycolytic abnormality. Arch. Neurol. 17, 248 (1967).PubMedCrossRefGoogle Scholar
  49. Schimrigk, K., H. G. Mertens, K. Ricker, J. Führ, P. Eyer u. D. Pette: McArdle-Syndrome (Myopathie bei feldender Muskelphosphorylase). Klin. Wschr. 45, 1 (1967).PubMedCrossRefGoogle Scholar
  50. Schmid, R., and R. Mahler: Chronic progressive myopathy with myoglobinuria demonstration of a glycogenolytic defect in the muscle. J. clin. Invest. 38, 2 (1959).CrossRefGoogle Scholar
  51. Schmid, R., and L. Hammaker: Hereditary absence of muscle phosphorylase (McArdle’s syndrome). N. Engl. J. Med. 264, 223 (1961).PubMedCrossRefGoogle Scholar
  52. Schotland, D. L., S. Spiro, L. P. Rowland, and P. Carmel: Ultrastructural studies of muscle in McArdle’s disease. J. Neuropath, exp. Neurol. 24, 629 (1965).CrossRefGoogle Scholar
  53. Sidbury, J. B. jr.: The genetics of the glycogenosis affecting muscle. In: Exploratory concepts in muscular dystrophy and related disorders. Ed.: A. T. Milhorat. Amsterdam-New York-London: Excerpta Medica Foundation. 1967.Google Scholar
  54. Smith, H. L., L. D. Amick, and J. B. Sidbury, jr.: Type II glycogenosis. Amer. J. Diss. Child. 111, 475 (1966).Google Scholar
  55. Smith, J., H. Zellweger, and K. Afifi: Muscular form of glycogenosis, type II (Pompe). Report of a case with unusual features. Neurology 17, 537 (1967).PubMedGoogle Scholar
  56. Snapper, J., et S. van Creveld: Un cas d’hipoglicemie avec acetonemic chez un enfant. Bull. Soc. méd. Paris 52, 1315 (1928).Google Scholar
  57. Stein, E., G. W. Löhr, M. Eggstein, P. Schollmeyer, E. Anhegger u. E. Schairer: Familiäre Kardiomegalie im Erwachsenenalter infolge Glykogenspeicherung. Verh. dtsch. Ges. Kreisl.-Forsch. 1965, 138.Google Scholar
  58. Tarui, S., G. Okuno, Y. Ikura, T. Tanaka, M. Suda, and M. Nishikawa: Phosphofruktokinase deficiency in skeletal muscle. A new type of glycogenosis. Biochem. biophys. Res. Commun. 19, 517 (1965).Google Scholar
  59. Thomson, W. H. S., J. C. McLaurin, and J. W. Prineas: Skeletal muscle glycogenosis: an investigation of two dissimilar cases. J. Neurol. Neurosurg. Psychiat. 26, 60 (1963).PubMedCrossRefGoogle Scholar
  60. Tobin, R. W., and W. A. Coleman: A familv studv of phosphorvlase deficiencv in muscle. Ann. intern. Med. 62. 313 (1965).PubMedGoogle Scholar
  61. Vitek. B.. J. Valexta U. J. Sumbera: Glykogenose bei einem 21. jährigen Mädchen mit arteriovenöser Lungenfistel. Z. Kreisl.-Forsch. 56, 1032 (1967).Google Scholar
  62. Williams. H. E.. E. M. Kendig. and J. B. Field: Leukocyte debranching enzyme in glycogen storage disease. J. clin. Invest. 42, 656 (1963).Google Scholar
  63. Zellweger, H., B. Illingworth, W. F. McCormick, and J. B. Tu: A mild form of muscular glycogenosis in two brothers with alpha-1,4-glucosidase deficiency. Ann. Pediat. 205, 413 (1965).Google Scholar

Familiäre periodische Paralysen

  1. Aitken, R. S., E. N. Allot, L. J. M. Castleden, and M. Walker: Observations on a case of familial periodic paralysis. Clin. Sci. 3, 47 (1937).Google Scholar
  2. Allot, E. N., and B. McArdle: Further observations on familial periodic paralysis. Clin. Sci. 3, 229 (1938).Google Scholar
  3. Allsop, J. L., K. Goulston, C. Johnston, D. Kelly, and L. Rail: Familial hyperkalemic periodic paralysis. Austr. Ann. Med. 17, 55 (1964).Google Scholar
  4. Armstrong, F. S.: Hyperkaliemic familial periodic paralysis (adynamia episodica hereditaria). Ann. intern. Med. 57, 455 (1962).PubMedGoogle Scholar
  5. Arnould, G., P. Tridon, M. Laxenaire, M. Duc et M. Thiriet: Syndrome Myopathique au Cours d’une Paralysie périodique hypokaliemique. Presse Méd. 1, 1398 (1966).Google Scholar
  6. Becker, P. E.: Myopathien. In: Handbuch der Humangenetik, Bd. 3, S. 1. Hrsg. P. E. Becker. Stuttgart: Thieme 1964.Google Scholar
  7. Bekeny, G., T. Hasznos U. F. Solti: Über die hyperkaliämische Form der paroxysmalen Lähmung. Zur Frage der Adynamia episodica hereditaria. Dtsch. Z. Nervenheilk. 182, 92 (1961).CrossRefGoogle Scholar
  8. Bickerstaff, E. R.: Periodic paralysis. J. Neurol. Neurosurg. Psychiat. 16, 178 (1953).PubMedCrossRefGoogle Scholar
  9. Biemond, A., and A. P. Daniels: Familial periodic paralysis and its transition into spinal muscular atrophy. Brain 57, 91 (1934).CrossRefGoogle Scholar
  10. Bogaert, L. van, P. Kissel, J. Schmitt, J. J. Martin, C. Claes, M. Duc, R. Royer, D. Barrucand, J. Grignon et J. Floquet: Syndrome myopathique au cours d’une maladie de Gamstorp. Acta neurol. belg. 67, 133 (1967).Google Scholar
  11. Bredemann, W.: Über paroxysmale Lähmung bei dystrophischer Myotonie. Ärztl. Wschr. 7, 202 (1952).Google Scholar
  12. Buchthal, F., L. Engback, and I. Gamstorp: Paresis and hyperexcitability in adynamia episodica hereditaria. Neurology 8, 347 (1958).PubMedGoogle Scholar
  13. Carson, M. J., and C. M. Pearson: Familial hyperkalemic periodic paralysis with myotonic features. J. Pediat. 64, 853 (1964).PubMedCrossRefGoogle Scholar
  14. Casteigne, P., et H. Collomb: Maladie familiale héréditaire avec crises paralytiques prédominant aux membres inférieurs. Rev. neurol. 100, 14 (1959).Google Scholar
  15. Conn, J. W., S. S. Fajans, L. H. Louis, D. H. P. Streeten, and R. D. Johnson: Intermittent aldosteronism in periodic paralyses. Lancet 1957I, 802.Google Scholar
  16. Conn, J. W., and D. H. P. Streeten: Periodic paralysis. In: The metabolic basis of inherited disease. Ed. J. B. Stanbury, J. B. Wyngaarden, and D. S. Frederickson. New York: McGraw-Hill 1960.Google Scholar
  17. Coppen, A. J., and E. H. Reynolds: Electrolyte and water distribution in familial hypo¬kalemic periodic paralysis. J. Neurol. Neurosurg. Psychiat. 29, 107 (1966).CrossRefGoogle Scholar
  18. Creutzfeldt, O. D.: Die episodische Adynamie (Adynamia episodica hereditaria Gamstorp), eine familiäre hyperkaliämische Lähmung. Fortschr. Neurol. Psychiat. 10, 529 (1961).Google Scholar
  19. Creutzfeldt, O. D., Membranpotentiale in menschlichen Muskeln bei gesunden Personen und Patienten mit Adynamia episodica hereditaria und periodischer Lähmung. Naturwissenschaften 49, 284 (1962).CrossRefGoogle Scholar
  20. Creutzfeldt, O. D., B. C. Abbot, W. M. Fowler, and C. M. Pearson: Muscle membrane potentials in episodic adynamia. Electroenceph. clin. Neurophysiol. 15, 508 (1963).Google Scholar
  21. Danowski, T. S., J. R. Elkinton, B. A. Burrows, and A. W. Winkler: Exchanges of sodium and potassium in familial periodic paralysis. J. clin. Invest. 27, 65 (1948).CrossRefGoogle Scholar
  22. Dieckmann, H., H. G. Mertens, K. D. Voigt u. U. Volkwein: Die Rolle des Aldosterons bei der paroxysmalen Lähmung. Klin. Wschr. 41, 178 (1963).PubMedCrossRefGoogle Scholar
  23. Doak, P. B., E. D. Eyre: Adynamia episodica hereditaria or hyperkalemic periodic paralysis. N. Z. med. J. 60, 19 (1961).PubMedGoogle Scholar
  24. Egan, T. J., and R. Klein: Hyperkalemic familial periodic paralysis. Pediatrics. 24, 761 (1959).PubMedGoogle Scholar
  25. Engel, A. G.: Thyroid function and periodic paralysis. Amer. J. Med. 30, 327 (1961).PubMedCrossRefGoogle Scholar
  26. Engel, A. G., E. H. Lambert, J. W. Rosevear, and W. N. Tauxe: Clinical and electromyographic studies in a patient with primary hypokalemic periodic paralysis. Amer. J. Med. 38, 626 (1965).PubMedCrossRefGoogle Scholar
  27. Engel, A. G., C. S. Potter, and J. W. Rosevear: Studies on carbohydrate metabolism and mitochondrial respiratory activities in primary hypokalemic periodic paralysis. Neurology 17, 329 (1967).PubMedGoogle Scholar
  28. Ferre-Milone, F., and A. Pacchiani: Nerve conduction velocity, spontaneous and evoked potentials in the dyskaliemic paralysis (a study of two cases, mother and son). In: Neuromuskuläre Erkrankungen, 8. Int. Kongress für Neurologie TOM II, Vienna 1965.Google Scholar
  29. Gamstorp, I.: Adynamia episodica hereditaria. Lund: Hakan Ohlssons 1956.Google Scholar
  30. Gamstorp, I., M. Hauge, H. F. Helweg-Larsen, H. Mjönes, and U. Sagild: Adynamia episodica hereditaria. A disease clinically resembling familial periodic paralysis but characterized by increasing serum potassium during the paralytic attacks. Amer. J. Med. 23, 385 (1957).PubMedCrossRefGoogle Scholar
  31. Gamstorp, I., A study of transient muscular weakness. Acta neurol. scand. 38, 3 (1962).PubMedCrossRefGoogle Scholar
  32. Gamstorp, I., Adynamia episodica hereditaria and myotonia. Acta neurol. scand. 39, 41 (1963).PubMedCrossRefGoogle Scholar
  33. Goldflam, S.: Weitere Mitteilung über die paroxysmale, familiäre Lähmung. Dtsch. Z. Nervenheilk. 7, 1 (1895).CrossRefGoogle Scholar
  34. Grob, A., Ä. Liljestrand, and R. J. Johns: Potassium movement in normal subjects: effect on muscle function. Amer. J. Med. 23, 340 (1957).Google Scholar
  35. Grob, A., R. J. Johns, and Ä. Liljestrand: Potassium movement in patients with familial periodic paralysis. Relationship to the defect in muscle function. Amer. J. Med. 23, 356 (1957).Google Scholar
  36. Gruner, J. E., et A. Porte: Les lésions musculaires dang la paralysie périodique familiale. Rev. neurol. 101, 501 (1959).PubMedGoogle Scholar
  37. Van t’Hoff, W.: Familial myotonic periodic paralysis. Quart. J. Med. 31, 385 (1962).Google Scholar
  38. Holtzapple, G. E.: Periodic paralysis. J. Amer. med. Ass. 1905, 1224.Google Scholar
  39. Howes, E. L., jr., H. M. Price, C. M. Pearson, and J. M. Blumberg: Hypokalemic periodic paralysis. Electromicroscopic changes in the sarcoplasm. Neurology 16, 242 (1966).Google Scholar
  40. Hudson, A. J., K. P. Strickland, and A. Wilensky: Serum enzyme changes in high serum potassium periodic paralysis. Excerpta Medica Foundation Int. Congress Series No. 154, 12 (1967).Google Scholar
  41. Iversen, I. O.: Familial episodic adynamia. Acta med. scand. 171, 737 (1962).CrossRefGoogle Scholar
  42. Jaffurs, W. J., R. H. Herman, M. K. Mcdowell, and J. Blumberg: Hyperkalemic paralysis (adynamia episodica hereditaria) ultrastructural studies of muscle in two cases. Metabolism 12, 740 (1963).PubMedGoogle Scholar
  43. Jantz, H.: Stoffwechseluntersuchungen bei paroxysmaler Lähmung. Nervenarzt 18, 360 (1947).Google Scholar
  44. Kaplan, M., P. Straus, R. Grumbach et B. Aymard: L’adynamie episodique hereditaire. Presse méd. 56, 1305 (1957).Google Scholar
  45. Klein, R., T. Egan, and P. Usher: Changes in radium potassium and water in hyperkaliemic familial periodic paralysis. Metabolism 9, 1005 (1960).PubMedGoogle Scholar
  46. Klein, R., and P. Usher: Effects of external cooling of the leg on muscle intracellular water and potassium. Proc. Soc. exp. Biol. (N. Y.) 106, 784 (1961).Google Scholar
  47. Kreindler, A., V. Ionasesco, I. Petrovici, Ar. Petresco et G. Calcainu: Etudes cliniques et de laboratoire dans la paralysie périodique familiale avec hypokaliemie. Rev. neurol. 110, 377 (1964).Google Scholar
  48. Krull, G. H., B. Leijnse, W. P. J. Vietor, M. de Vlieger, J. W. G. Ter Braak, and J. Gerbrandy: Myotonia produced by an unknown humoral substance. Lancet 1966II, 668.Google Scholar
  49. Kuhn, E.: Myotonia. In: Proceedings of the Second Congress of Neurogenetic, Neuro-opthalmology etc. Ed. A. Barbeau. Amsterdam-New York-London: Excerpta Medica Foundation (im Druck).Google Scholar
  50. Layzer, R. B., E. R. Lovelace, and L. P. Rowland: Hyperkalemie periodic paralysis. Arch. Neurol. (Chic.) 16, 455 (1967).CrossRefGoogle Scholar
  51. Liljestrand, Ä.: Fall av adynamia episodica hereditaria. Opusc. med. (Stockh.) 7, 1 (1957).Google Scholar
  52. McArdle, B.: Familial periodic paralysis. Brit. med. Bull. 12, 226 (1956).Google Scholar
  53. McArdle, B., Adynamia episodica hereditaria and its treatment. Brain 85, 121 (1962).CrossRefGoogle Scholar
  54. McArdle, B., Metabolic myopathies. The glykogenoses affecting muscle and hypo- and hyperkalemie periodic paralysis. Amer. J. Med. 35, 661 (1963).PubMedCrossRefGoogle Scholar
  55. McFadzean, A. J. S., and R. Yeung: Periodic paralysis complicating thyrotoxicosis in Chinese. Brit. med. J. 1967I, 451.Google Scholar
  56. Mertens, H. G., K. Schimrigk, U. Volkwein u. K. D. Voigt: Elektrolyt- und Aldolsteron-stoffwechsel bei der Adynamia episodica hereditaria, der hyperkaliämischen Form der periodischen Lähmung. Klin. Wschr. 42, 5 (1964).CrossRefGoogle Scholar
  57. Mertens, H. G., u. M. Lurati: Mineralhaushalt bei periodischen Lähmungen. Symposium vom 27. 2. bis 1. 3. 1967, Frankfurt, Hrsg. G. Kienle. Stuttgart: Thieme 1967.Google Scholar
  58. van der Meulen, J. P., G. J. Gilbert, and C. A. Kane: Familial hyperkalemie paralysis with myotonia. New Engl. J. Med. 264, 1 (1961).Google Scholar
  59. Morrison, J. B.: The electromyographic changes in hvperkalemic familial periodic paralvsis. Ann. phys. Med. 5, 153 (1960).PubMedGoogle Scholar
  60. Niall, J. F., and R. K. Pak Poy: Studies in familial hvpokalaemic periodic paralvsis. Austr. Ann. Med. 1966, 352.Google Scholar
  61. Okinaka. S.. K. Shizume. S. Jino. A. Watanabe. and T. Ito: The association of periodic paralvsis and hyperthyroidism in Japan. J. clin. Endocr. 17, 1454 (1957).PubMedCrossRefGoogle Scholar
  62. Pearce. G. W.: Tissue culture and electron microscopy in muscle disease. In: Disorders of voluntary muscle. Ed.: J. N. Walton. Boston: Little, Brown 1964.Google Scholar
  63. Pearson, C. M.: The periodic paralysis: differential features and pathological observations in permanent myopathic weakness. Brain 87, 341 (1964).PubMedCrossRefGoogle Scholar
  64. Poskanzer, D. C., and D. N. S. Kerr: A third type of periodic paralysis, with normokalemia and favourable response to sodium chloride. Amer. J. Med. 31, 328 (1961).PubMedCrossRefGoogle Scholar
  65. Resnick, J. S.: Episodic muscle weakness. In: Current concepts of myopathies. Ed.: W. K. Engel. Philadelphia-Montreal: Lippincott 1965.Google Scholar
  66. Resnick, J. S., and W. K. Engel: Myotonic lid lag in hypokalemic periodic paralysis. J. Neurol. Neuro- surg. Psychiat. 30, 47 (1967).CrossRefGoogle Scholar
  67. Riecker, G., u. H. D. Bolte: Membranpotentiale einzelner Skelettmuskelzellen bei hypokaliämischer periodischer Muskelparalyse. Klin. Wschr. 44, 804 (1966).PubMedCrossRefGoogle Scholar
  68. Rowley, P. T., and B. Kliman: The effect of sodium loading and depletion on muscular strength and aldosterone excretion in familial periodic paralysis. Amer. J. Med. 28, 376 (1960).PubMedCrossRefGoogle Scholar
  69. Sagild, U., og H. F. Helweg-Larsen: Det kliniske billede ved arvelige transitoriske muskellammelser. Nord. med. 53, 981 (1955).Google Scholar
  70. Sagild, U., Hypoglycemia induced by potassium administration during attacks of periodic paralysis. Acta med. scand. 178, 329 (1963).Google Scholar
  71. Samaha, F. J.: Hyperkalemie periodic paralysis. A genetic study, clinical observations and report of a new method of therapy. Arch. Neurol. (Chic.) 12, 145 (1965).CrossRefGoogle Scholar
  72. Satoyoshi, E., Y. Suzuki, and T. Abe: Periodic paralysis: A study of carbohydrate and thiamine metabolism. Neurology 13, 24 (1963).PubMedGoogle Scholar
  73. Satoyoshi, E., K. Murakawi, H. Kowa, M. Kinoshita, and Y. Nishiyama: Periodic paralysis in hyperthyroidism. Neurology 13, 746 (1963).PubMedGoogle Scholar
  74. Shy, G. M., T. Wanko, P. T. Rowley, and A. G. Engel: Studies in familial periodic paralysis. Exp. Neurol. 3, 53 (1961).CrossRefGoogle Scholar
  75. Sestoft, L.: Direct transition from hypo- to hyperkalaemic paralysis during potassium treatment of familial periodic paralysis. Dan. med. Bull. 14, 157 (1967).PubMedGoogle Scholar
  76. Talbott, J. H.: Periodic paralysis; clinical syndrome. Medicine 20, 85 (1941).CrossRefGoogle Scholar
  77. Talso, P. J., M. F. Glynn, Y. T. Oester, and J. Fudema: Body composition in hypokalemic familial periodic paralysis. Ann. N. Y. Acad. Sci. 110, 993 (1963).PubMedCrossRefGoogle Scholar
  78. Turpin, R., B. Caille, J. Lafourcade, M. Bebe, M. Malafosse, P. Nayrac, P. Warot, P. Fossati, G. Milbled et S. Meihnie: Maladie familiale prenant chez certains sujets l’aspect d’une paramyotonie d’Eulenburg et rappelant chez d’autres l’adynamie épisodique héréditaire. Presse méd. 72, 3179 (1964).PubMedGoogle Scholar
  79. Tyler, F. H., F. E. Stephens, F. D. Gunn, and G. T. Perkoff: Studies in disorders of muscle VII, clinical manifestations and inheritance of type of periodic paralysis without hypo-potassemia. J. clin. Invest. 30, 492 (1951).PubMedCrossRefGoogle Scholar
  80. Vastola, E. F., and C. A. Bertrand: Intracellular water and potassium in periodic paralysis. Neurology 6, 523 (1956).PubMedGoogle Scholar
  81. Vaughan, Jones, R., R. R. McSwiney, and R. V. Brooks: Periodic paralysis sodium metabolism and aldosterone output. Lancet 1959I, 177.Google Scholar
  82. Westphal, C.: Über einen merkwürdigen Fall von periodischer Lähmung aller vier Extremitäten mit gleichzeitigem Erlöschen der elektrischen Erregbarkeit während der Lähmung. Berl. klin. Wschr. 22, 489 (1885).Google Scholar
  83. Woratz, G.: Hvpokaliämische paroxvsmale Lähmung. Eine Sippenbeobachtung. Münch, med. Wschr. 107, 2318 (1965).Google Scholar

Übrige

  1. Becker, P. E., U. G. von Knorre: Klinik der Mvositis ossificans progressiva. Ergebn. inn. Med. Kinderheilk. 27, 1 (1988).Google Scholar
  2. Engel, W. K.: Muscle biopsie. In: Current concepts of myopathies. Ed. W. K. Engel: Philadelphia-Montreal: Lippincott Comp. 1965.Google Scholar
  3. Hed, R.: Mvoglobinuria in man with special reference to a familial form. Acta med. scand. 171, 585 (1962).PubMedCrossRefGoogle Scholar
  4. Hinz, C. F. jr., W. R. Drucker, and J. Larner: Idiopathic myoglobinuria metabolic and enzymatic studies on three patients. Amer. J. Med. 39, 49 (1965).PubMedCrossRefGoogle Scholar
  5. Koontz, A. R.: Myositis ossificans progressiva. Amer. J. med. Sci. 174, 406 (1927).CrossRefGoogle Scholar
  6. Mair, W. F.: Myositis ossificans progressiva. Edinb. med. J. 39, 13 (1932).Google Scholar
  7. Mallet, R., M. Ribierre, B. Labrune et L. Reyrole: La myoglobinurie paroxystique idio- pathique. Soc. Med. Hop. Paris 116, 785 (1965).Google Scholar
  8. Schlatter, Ch.: Über einen Fall von idiopathischer paroxysmaler Mvoglobinurie. Dtsch. Arch. klin. Med. 209, 445 (1964).PubMedGoogle Scholar
  9. Smith, D. M., W. Zeman, C. C. Johnston jr., and W. P. Deiss jr.: Myositis ossificans progressiva. Case report with metabolic and histochemical studies. Metab. clin. Exp. 15, 521 (1966).Google Scholar
  10. Stempel, W.: Die sogenannte Myositis ossificans progressiva. Mitt. Grenzgeb. med. Chir. 3, 394 (1898).Google Scholar
  11. Tünte, W., P. E. Becker u. G. v. Knorre: Zur Genetik der Myositis ossificans progressiva. Humangenetik 4, 320 (1967).PubMedCrossRefGoogle Scholar
  12. Uehlinger, E.: Myositis ossificans progressiva. Ergebn. med. Strahlenforsch. 7, 175 (1936).Google Scholar
  13. Viparelli, U.: La miosite ossificante progressiva. Ann. Neuropsichiat. Psicoanal. 10, 571 (1963).Google Scholar
  14. Wheby, M. S., and H. S. Miller: Idiopathic paroxysmal myoglobinuria: report of 2 cases occuring in sisters. Amer. J. Med. 29, 599 (1960).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1969

Authors and Affiliations

  • E. Kuhn
    • 1
  1. 1.Medizinischen PoliklinikUniversität HeidelbergDeutschland

Personalised recommendations